For older version click here.

Please wait...

Browsing by Peptides

This page helps to browse unique peptides in CancerPPD 2.0. User can get detailed information of a particular peptide by clicking on a peptide sequence. For more information, please see the User Guide.

Peptides Sequence Total Entries Total Cell Lines Total Assays
#2(D33-N52)
RRRRRRRRGGDRDYKKFWAGLQGLTIYFYN 2 2 1
#5(D93-F112)
RRRRRRRRGGDQEIKFKVETLECREMWKGF 1 1 1
#6(M108-L127)
RRRRRRRRGGMWKGFILTVVELRVPTDLTL 2 2 1
(HHPHG)2
HHPHGHHPHG 2 1 1
(HHPHG)3
HHPHGHHPHGHHPHG 2 1 1
(HHPHG)4
HHPHGHHPHGHHPHGHHPHG 2 1 1
(LLKK)4 linear peptide
LLKKLLKKLLKKLLKK 4 4 1
0Dap
GIKKWLHSAKKFGKKFVKKIZNS 1 1 1
1
WQWRWQW 2 2 1
1-R
WQWRWQWR 2 2 1
10
YSA* 20 6 1
11
GLFDVIKKVASVIKGL 9 9 1
13
GLFDVIKKVASVIKKL 9 9 1
14
GLFDVIAKVASVIKKL 9 9 1
14G
ALWKSILKNAGKAGLNEINQIVQ 2 2 1
14V
ALWKSILKNAGKAVLNEINQIVQ 2 2 1
14V5K
ALWKKILKNAGKAVLNEINQIVQ 2 2 1
14VL23
ALWKSILKNAGKAVLNEINQIV 2 2 1
15
GLFAVIKKVASVIKGL 34 16 2
16
GLFAVIKKVASVIKKL 33 16 2
17
GLFAVIKKVAAVIKKL 34 16 2
17BIPHE2
GBKRLVQRLKDBLRNLV 2 2 1
18
GLFAVIKKVAAVIRRL 35 16 2
19
GLFAVIKKVAKVIKKL 9 9 1
1[dR] 5[Orn] [Pal]
rWQWOWQWR 1 1 1
1[dR][Pal]
rWQWRWQWR 1 1 1
1[Orn] [Pal]
OWQWRWQWR 1 1 1
2-arm branched peptide
[LLKKLLKK]2kC 4 4 1
22
GLFKVIKKVASVIGGL 9 9 1
23
GLFKVIKKVAKVIKKL 22 15 2
2A(F39-Q58)
RRRRRRRRGGFWAGLQGLTIYFYNSNRDFQ 1 1 1
2C(Q44-Q58)
RRRRRRRRGGQGLTIYFYNSNRDFQ 1 1 1
2D(Q44-R55)
RRRRRRRRGGQGLTIYFYNSNR 1 1 1
2D2(Q44-Y51)
RRRRRRRRGGQGLTIYFY 1 1 1
2D3(G45-N52)
RRRRRRRRGGGLTIYFYN 1 1 1
2D5(G45-Y51)
RRRRRRRRGGGLTIYFY 1 1 1
2Dap
GIKXWLHSAKKFGXKFVKKIZNS 1 1 1
3
GLFAVIKKVASVIGGL 9 9 1
37-mer peptide
TKEQKEQIAKATGLTTKQVRNWYVQLNASIKVCMCSC 3 3 1
3A
LTAEHYAAQATS 2 1 1
4-arm branched peptide
{[LLKKLLKK]2kC}2 4 4 1
4Dap
GIKXWLHSAXKFGXKFVKXIZNS 1 1 1
5
GLFDVIKAVASVIGGL 9 9 1
5-2C
NYPQRPCRGDKGPDC 12 12 1
5[Orn] [Pal]
RWQWOWQWR 1 1 1
6Dap
GIKXWLHSAXXFGXKFVXXIZNS 1 1 1
6E(V116-M135)
RRRRRRRRGGVVELRVPTDLTLLPGHLYMM 1 1 1
6F (I113-P122)
RRRRRRRRGGILTVVELRVP 1 1 1
7
GLFDVIKKVAAVIGGL 9 9 1
8
YA* 25 7 1
8Dap
GIXXWLHSAXXFGXXFVXXIZNS 1 1 1
9
YSA* 25 7 1
9R
RRRRRNWMWC 13 4 1
9S1R
RRRRRWCMNW 13 4 1
9[Orn] [Pal]
RWQWRWQWO 3 3 1
A11
EYVQTVKSSKG 3 3 1
A12D
KWKSFLKTFKSaKKTVLHTALKAISS 4 4 1
A12D/V16D
KWKSFLKTFKSaKKTvLHTALKAISS 4 4 1
A12L
KWKSFLKTFKSLKKTVLHTALKAISS 8 8 1
A12L/A20L
KWKSFLKTFKSLKKTVLHTLLKAISS 8 8 1
A12L/A20L/A23L
KWKSFLKTFKSLKKTVLHTLLKLISS 8 8 1
A20L
KWKSFLKTFKSAKKTVLHTLLKAISS 8 8 1
A4K14 - Citropin 1.1
GLFAVIKKVASVIKGL 4 4 1
A4K14 - Citropin 1.1 - Sp 1
GS5FAVS5KKVASVIKGL 4 4 1
A4K14 - Citropin 1.1 - Sp 2
GLFAS5IKKS5ASVIKGL 4 4 1
A4K14 - Citropin 1.1 - Sp 3
GLFAVS5KKVS5SVIKGL 4 4 1
A4K14 - Citropin 1.1 - Sp 4
GLFAVIKKS5ASVS5KGL 4 4 1
A4K14 - Citropin 1.1 - Sp 5
GLFAVIKKVAS5VIKS5L 4 4 1
A4K14 - Citropin 1.1 - Sp 6
GR8FAVIKKS5ASVIKGL 4 4 1
A4K14 - Citropin 1.1 - Sp 7
GLFAVR8KKVASVS5KGL 4 4 1
A4W-GGN5
FLGWLFKVASK 2 2 1
A5
KAQIRAMECNIL 1 1 1
AaeAP1a
FLFKLIPKAIKGLVKAIRK 3 3 1
AaeAP2a
FLFKLIPKVIKGLVKAIRK 3 3 1
AAP-H
YVPGP 1 1 1
ABP-dHC-Cecropin A
RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK 3 3 1
ABP-dHC-Cecropin A-K(24)
RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK 3 3 1
AC-P19
FAKKLAKLKKKLAKLALAL 2 2 1
AC-P19M
FAKKLAKLKKKLAKLAKKR 2 2 1
Adenoregulin
GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV 5 5 1
AEM-28
LRKLRKRLLRDWLKAFYDKVAEKLKEAF 5 5 1
AEM-28–2
Aha-LRRLRRRLLRDWLKAFYDKVAEKLKEAF 5 5 1
Ahx-[Pal]
Ahx-RWQWRWQWR 2 2 1
ALA-A2
KLWCKSSQVPQSR 2 2 1
Alloferon 1
HGVSGHGQHGVHG 1 1 1
Alpha-gliadin peptide p31-43
LGQQQPFPPQQPY 4 3 2
ALRN-6924
LTFAEYWAQLaAAAAAa 1 1 1
AMP-WF3
FLKSLWRGVKAIFNGARQGYKEHKN 1 1 1
AMP1
WKWLKKWIK 1 1 1
AMP2
KRWWKWWRR 1 1 1
Anubis-2
FAKKLAKKLKKLAKKLAKLAKKL 7 6 1
AP
ACDCRGDCFCGGGGIVRRADRAAVP 3 1 1
AP(O)
ACDCRGDCFCGGGGIVRRADRAAVP 3 1 1
AP1-Z1
FLFSLIPHAISGLISAFK 3 3 1
AP1-Z3a
FLFSLIKHAIKGLISAFK 3 3 1
AP1-Z3b
FLFSLIKHAISKLISAFK 3 3 1
AP1-Z5a
FLFKLIPKAIKGLIKAFK 3 3 1
AP1-Z5b
FLFKLIKHAIKGLIKAFK 3 3 1
AP1-Z7
FLFKLIKKAIKKLIKAFK 3 3 1
AP1-Z9
FLFKLIKKKIKKLIKKFK 3 3 1
Api8-NH2
UGLUGGLZGI 1 1 1
Apo E
LRVRLASHLRKLRKRLLRDADDLQKRLAVY 5 5 1
Ascaphin-8
GFKDLLKGAAKALVKTVLF 1 1 1
At10
IKKIIKIIKKIIKKI 2 2 1
At11
IIIKKIKKKIKKIII 2 2 1
At12
KIIIKIKKKIKIIIK 2 2 1
At4
KLLKKLLKLLKKLLK 2 2 1
At5
KIIKKIIKIIKKIIK 2 2 1
At6
KVVKKVVKVVKKVVK 2 2 1
At7
KIIKKIKKKIKKIIK 2 2 1
At8
KLLKKLKKKLKKLLK 2 2 1
At9
KVVKKVKKKVKKVVK 2 2 1
ATMP1
THPPTTTTTTTTTTTYTAAPATTT 3 2 1
AtMP2
TGIATSGLATFTLHTGSLAPAT 2 2 1
ATMP5
THPPTTTTTTTTTTTYTAAPATTT 1 1 1
ATRA1-R3W2 - HYD
RRWKRFFKRWKGGVIGVTFPF 1 1 1
ATX-101
MDRWLVKWKKKRKIRRRRRRRRRRR 12 12 1
Aurein 1.1
GLFDIIKKIAESI 1 1 1
Aurein 1.2_mutant (Aurm)
GLFDIIKKIIKSF 2 2 1
Aurein 1.2_mutant_R5 (R5-Aurm)
RRRRRGLFDIIKKIIKSF 2 2 1
Aurein 1.2_R5 (R5-Aur)
RRRRRGLFDIIKKIAESF 2 2 1
Aurein 2.1
GLLDIVKKVVGAFGSL 1 1 1
Aurein 2.2
GLFDIVKKVVGALGSL 1 1 1
Aurein 2.3
GLFDIVKKVVGAIGSL 1 1 1
Aurein 2.4
GLFDIVKKVVGTLAGL 1 1 1
Aurein 3.1
GLFDIVKKIAGHIAGSI 9 9 1
Aurein 3.2
GLFDIVKKIAGHIASSI 9 9 1
Aurein 3.3
GLFDIVKKIAGHIVSSI 9 9 1
Aurein1.2
GLFDIIKKIAESF 9 9 1
Aurein2.5
GLFDIVKKVVGAFGSL 9 9 1
Aurein2.6
GLFDIAKKVIGVIGSL 9 9 1
B1
KKLFKKILKYLK 8 4 1
B1-Ala14
VKRFKKFFRKLKKAV 2 2 1
B1-Arg
VKRFKKFFRKLKKRV 2 2 1
B1-Asp
VKRFKKFFRKLKKDV 2 2 1
B1-Gln
VKRFKKFFRKLKKQV 2 2 1
B1-Glu
VKRFKKFFRKLKKEV 2 2 1
B1-Gly
VKRFKKFFRKLKKGV 2 2 1
B1-His
VKRFKKFFRKLKKHV 2 2 1
B1-Leu
VKRFKKFFRKLKKLV 4 4 1
B1-Lys
VKRFKKFFRKLKKKV 4 4 1
B1-Phe
VKRFKKFFRKLKKFV 2 2 1
B1-Thr
VKRFKKFFRKLKKTV 2 2 1
B1-Val
VKRFKKFFRKLKKVV 2 2 1
B11
RIRDAIAHGYIVDKV 3 3 1
B1AW
FLPLLAGLAANFLPQIICKIARKC 3 3 1
B1AW-K
FLPLLAGLAANFLPKIICKIARKC 3 3 1
B1OS
FPLIASLAGNVVPKIFCKITKRC 5 5 1
B1OS-D-L
FlPLIASLAGNVVPKIFCKITKRC 5 5 1
B1OS-L
FLPLIASLAGNVVPKIFCKITKRC 5 5 1
B2
KKLFKKILKYLKK 4 4 1
B3
KKLFKKILKYLKKL 3 3 1
B4
LKKLFKKILKYL 5 4 2
B5
LKKLFKKILKYLK 4 4 1
B6
LKKLFKKILKYLKK 4 4 1
B7
KKLFKKILKY 3 3 1
B8
LKKLFKKILKY 5 4 2
B9
KLKKLFKKILKY 4 4 1
BAA-1
Structure Given 1 1 1
BAA-2
Structure Given 1 1 1
Baceridin
Wa(D-allo-i)VlL 3 3 1
Balixafortide
ACSAp(Dab)RYCYQKpPYH 3 3 1
BF2d
TRSSRAGLQWPVGRVHRLLRKGGC 3 1 1
BK-1
rRP-Hyp-G-Thi-S-Apc-Thi-R 1 1 1
BK-2
rRP-Hyp-G-Thi-S-f-Apc-R 1 1 1
BK-3
Aaa-rRP-Hyp-G-Thi-S-Acc-Thi-R 1 1 1
BK-4
Aaa-rRP-Hyp-G-Thi-S-f-Acc-R 1 1 1
BK-5
rRP-Hyp-G-Thi-S-f-(L)Pip-R 1 1 1
BK-6
Aaa-rRP-Hyp-G-Thi-S-(D)Pip-(L)Pip-R 1 1 1
BK-7
rRP-Hyp-G-Thi-S-(D)Pip-Thi-R 1 1 1
BK-8
Aaa-rRP-Hyp-G-Thi-S-(D)Pip-Thi-R 1 1 1
bLF
FKCRRWQWRMKKLGAPSITCVRRAF 2 2 1
BLP-7
GIGGALLSAGKSALKGLAKGLAEHFAN 6 6 1
BMAP-27
GRFKRFRKKFKKLFKKLSPVIPLLHL 3 3 2
BMAP-28
GGLRSLGRKILRAWKKYGPIIVPIIRIG 1 1 1
Bmkn-21
FIGAIARLLSKI 1 1 1
Bmkn-22
FIGAIARLLSK 1 1 1
BmKn-23
FIGAIARLLS 1 1 1
BmKn-24
FIGAIARLL 1 1 1
BmKn2
FIGAIARLLSKIF 1 1 1
BmPLA2
FKWQFEMLIMKIAKTSGFMFYSSY 2 2 1
Bombinin H-BO
IIGPVLGLIGKALGGLL 6 6 1
Bombinin-BO1
GIGSAILSAGKSIIKGLAKGLAEHF 3 3 1
Bombinin-H-BO1
IIGPVLGLVGKALGGLL 3 3 1
Bovine Lactoferricin (LfcinB)
FKCRRWQWRMKKLGAPSITCVRRAF 4 4 1
BP100
KKLFKKILKYL 5 4 2
BPP-II
MTLTG 14 3 1
BR-C
CKLKNFAKGVAQSLLNKASKLSGQC 2 2 1
BR-D
KlKNFAKGVAQSllNKASCKlSGQC 2 2 1
branched tetrapeptide Schiff bases derivative 5c
Figure given in Scheme 1 1 1 1
branched tetrapeptide Schiff bases derivative 4a
Figure given in Scheme 1 1 1 1
branched tetrapeptide Schiff bases derivative 4b
Figure given in Scheme 1 1 1 1
branched tetrapeptide Schiff bases derivative 4c
Figure given in Scheme 1 1 1 1
branched tetrapeptide Schiff bases derivative 5d
Figure given in Scheme 1 1 1 1
branched tetrapeptide Schiff bases derivative 5e
Figure given in Scheme 1 1 1 1
Brevinin-1BLa
FLPVIAGVAANFLPKLFCAISKKC 6 1 1
Brevinin-1BYa
FLPILASLAAKFGPKLFCLVTKKC 1 1 1
Brevinin-1GHd
FLGALFKVASKLVPAAICSISKKC 4 4 1
Brevinin-1H
FALGAVTKVLPKLFCLITRKC 4 4 1
Brevinin-1Ha
FALGAVTCLIRTKCKVLPKLF 4 4 1
Brevinin-1HL
FLGALFKVASKLVPAAICSISKKC 1 1 1
Brevinin-1HY
FALGAVTKVLYKLFCLITRKC 4 4 1
Brevinin-1RL1
FFPLIAGLAARFLPKIFCSITKRC 6 6 1
Brevinin-2DYb
GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC 4 4 1
Brevinin-2DYd
GIFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC 4 4 1
Brevinin-2R
KLKNFAKGVAQSLLNKASCKLSGQC 1 1 1
Buforin 2
TRSSRAGLQFPVGRVHRLLRK 1 1 1
Buforin IIb
RAGLQFPVGRLLRRLLRRLLR 58 58 1
Buforin2
TRSSRAGLQFPVGRVHRLLRK 1 1 1
C-1
KWKLFKKIPFLHLAKKF 3 3 1
C-10
KWKLFKKIPKFLH 3 3 1
C-2
KWKLFKKIPKFLHLAKK 3 3 1
C-3
KWKLFKKIPLHLAKKF 3 3 1
C-4
KWKLFKKIPKFLHLAK 3 3 1
C-5
KWKLFKKIPHLAKKF 3 3 1
C-6
KWKLFKKIPKFLHLA 3 3 1
C-7
KWKLFKKIPLAKKF 3 3 1
C-8
KWKLFKKIPKFLHL 3 3 1
C-9
KWKLFKKIPLKKF 3 3 1
C-Mel
CGIGAVLKVLTTGLPALISWIKRKRQQ 3 3 1
c1
KKWβ2,2WKK 2 1 1
C1 mother
GLTSK 3 3 1
C14-Liptotripeptide
KKK 1 1 1
C16-E4Y
EEEEY 4 4 1
C16-Lipotetrapeptide
KKKK 3 3 1
C16-Liptotripeptide
KKK 3 3 1
C1Triazole
GLTSK 3 3 1
c2
KW β2,2WKK 2 1 1
C2 mother
GEGSGA 3 3 1
C2Triazole
GEGSGA 3 3 1
c3
KK β2,2WKK 2 1 1
c4
KW β2,2KK 2 1 1
c5
KKW β2,2WKK 2 1 1
c6
KW β2,2WKK 2 1 1
c7
KK β2,2WKK 2 1 1
C7A
KILRGVAKKIMRTFLRRISKDILTGKK 21 9 2
C7A- Δ
KILRGVAKKIMRTFLRRILTGKK 4 1 1
C7A-D21K
KILRGVAKKIMRTFLRRISKKILTGKK 21 9 2
C7A-Δ
KILRGVAKKIMRTFLRRISKDILTGKK 17 9 2
c8
KW β2,2KK 2 1 1
CA (1-7) Shiva10 (1-16)
KWKLFKKKTKLFKKFAKKLAKKL 1 1 1
CA(1-& HECATE(11/23)
KWKLFKKALKKLKKALKKAL 7 6 1
CA(1-7) Shiva10(1-16)
KWKLFKKKTKLFKKFAKKLAKKL 3 3 1
CA(1-7) Shiva10(1-16)-COOH
KWKLFKKKTKLFKKFAKKLAKKL 6 5 1
CA(1-7)Shiva10(1-16)
KWKLFKKKTKLFKKFAKKLAKKL 4 3 1
CA-MA
KWKLFKKIGIGKFLHSAKKF 13 9 1
CA-MA-P
KWKLFKKIPKFLHSAKKF 3 3 1
CA-MA1
KWKLFKKIKFLHSAKKF 4 4 1
CA-MA2
KWKLFKKIPKFLHSAKKF 4 4 1
CA-MA3
KWKLFKKIGPGKFLHSAKKF 4 4 1
CA-ME
KWKLFKKIGIGAVLKVLTTG 3 3 1
CA4
CGPCFTTDHNMARKCDECCGGKGRGKCFGPQCLCR 1 1 1
Caerin 1.1
GLLSVLGSVAKHVLPHVVPVIAEHL 1 1 1
Caerin 1.10
GLLSVLGSVAKHVLPHVVPVIAEKL 1 1 1
Caerin 1.6
GLFSVLGAVAKHVLPHVVPVIAEK 1 1 1
Caerin 1.7
GLFKVLGSVAKHLLPHVAPVIAEK 1 1 1
Caerin 1.8
GLFKVLGSVAKHLLPHVVPVIAEK 1 1 1
Caerin 1.9
GLFGVLGSIAKHVLPHVVPVIAEK 1 1 1
CAME-15
KWKLFKKIGAVLKVL 7 6 1
Camel
KWKLFKKIGAVLKVL 4 4 1
Carnosine
(Beta-A)H 1 1 1
Caseinphosphopeptides
PPPEE 1 1 1
caspase 3 inhibitor
DEVD 3 1 1
Cationic Amphiphilic
GIIKKIIIKKIIIKKIIIKKI 6 2 1
CB
KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL 1 1 1
Cecropin 2
GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLK 1 1 1
Cecropin A
KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK 16 6 4
Cecropin B
KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL 25 17 4
Cecropin P1
SWLSKTAKKLENSAKKRISEGIAIAIQGGPR 4 4 1
cGm
GCRRLCYKQRCVTYCRGR 5 5 1
CH3CO-Ahx-[Pal]
CH3-CO-Ahx-RWQWRWQWR 1 1 1
ChaC11
IPCGESCVWIPCISGMFGCSCKDKVCYS 1 1 1
ChaC7
IPCGESCVWIPCITAIAGCSCKNKVCYT 1 1 1
Chassatide C10
GEYCGESCYLIPCFTPGCYCVSRQCVNKN 1 1 1
Chassatide C2
GIPCAESCVWIPPCTITALMGCSCKNNVCYNN 1 1 1
Chassatide C4
GDACGETCFTGICFTAGCSCNPWPTCTRN 2 1 1
Chassatide C8
AIPCGESCVWIPCISTVIGCSCSNKVCYR 1 1 1
Chaxapeptin
GFGSKPLDSFGLNFF 1 1 1
Chensinin-1b
SKVWRHWRRFWHRAHRLH 3 3 1
Chickpea
ADLPGLK 6 6 1
ChMAP-28
GRFKRFRKKLKRLWHKVGPFVGPILHY 5 5 1
ChMAP-29
GRFKRFRKKLKRLWHKVGPFVGPILHY 1 1 1
Chrysophsin-1
FFGWLIKGAIHAGKAIHGLIHRRRH 1 1 1
CI-15
CIIKKIIKKIIKKII 2 2 1
CIGB-300
GRKKRRQRRRPPQ-X-CWMSPRHLGTC 1 1 1
CIGB-552
HARIKpTFRRlKWKYKGKFW 3 3 1
Citropin 1.1
GLFDVIKKVASVIGGL 10 10 2
Citropin 1.1D
glfdvikkvasviggl 9 9 1
Citropin 1.2
GLFDIIKKVASVVGGL 1 1 1
Citropin 1.3
GLFDIIKKVASVIGGL 1 1 1
Citropin1.1
GLFDVIKKVASVIGGL 2 1 1
Cliotide T1
GIPCGESCVFIPCITGAIGCSCKSKVCYRN 1 1 1
Cliotide T2
GEFLKCGESCVQGECYTPGCSCDWPICKKN 1 1 1
Cliotide T3
GLPTCGETCTLGTCYVPDCSCSWPICMKN 1 1 1
Cliotide T4
GIPCGESCVFIPCITAAIGCSCKSKVCYRN 1 1 1
CM11
WKLFKKILKVL 2 2 1
cMP-C
CLNLKALLAVAKKILC 5 5 1
CM–FA
CGIGAVLKVLTTGLPALISWIKRKRQQ 3 3 1
Compound 2a
Structure in scheme 1 2 2 1
Compound 2b
Structure in scheme 1 2 2 1
Compound 2c
Structure in scheme 1 1 1 1
Compound 3a
Structure in scheme 2 1 1 1
Compound 3b
Structure in scheme 2 2 2 1
Compound 3c
Structure in scheme 2 2 2 1
Compound 4a
Structure in scheme 2 1 1 1
Compound 4b
Structure in scheme 2 2 2 1
Compound 4c
Structure in scheme 2 2 2 1
Compound 5a
Structure in scheme 2 2 2 1
Compound 5b
Structure in scheme 2 2 2 1
Compound 5c
Structure in scheme 2 2 2 1
Compound 6a
Structure in scheme 2 2 2 1
Compound 6b
Structure in scheme 2 2 2 1
Compound 6c
Structure in scheme 2 1 1 1
CopA3
LLCIALRKKLLCIALRKK 8 4 2
CPF-ST3
GLLGPLLKIAAKVGSNLL 1 1 1
Cr-ACP1
AWKLFDDGV 1 1 1
Crabrolin
FLPLILRKIVTAL 5 5 1
Crabrolin-4K
FLPKILRKIVTAL 5 5 1
Crabrolin-4R
FLPRILRKIVTAL 5 5 1
Crabrolin-AR
RLPRILRKIVRRL 5 5 1
Crabrolin-FR
RLPRILRKIVRAL 5 5 1
Crabrolin-PR
RLRRILRKIVRRL 5 5 1
Crabrolin-TR
FLPRILRKIVRAL 5 5 1
cT1
KWCFRVCYRGICYRRCRG 7 7 1
CTX-23
VCMPCFTTDQQMARKCSDCCGGKGRGKCYGPQCLCR 1 1 1
cyclic dipeptide - 1b
WG 4 4 1
cyclic dipeptide - 2b
WA 2 2 1
cyclic dipeptide - 3b
WL 2 2 1
cyclic dipeptide - 4a
WF 3 3 1
cyclic dipeptide - 4b
WF 4 4 1
cyclic dipeptide - 5b
WY 4 4 1
cyclic dipeptide - 6b
WW 4 4 1
cyclic dipeptide - 7b
WP 4 4 1
Cyclic [W(RW)4 ]-Dox
WRWRWRWRW 4 4 1
Cyclosaplin
RLGDGCTR 1 1 1
Cyclotide mela-6
GLPTCGETCFKGKCYTPGCSCSYPICKKD 2 2 1
Cycloviolacin O2
GIPCGESCVWIPCISSAIGCSCKSKVCYRN 1 1 1
CyO4
GIPCGESCVWIPCISSAIGCSCKNKVCYRN 1 1 1
D(KLAKLAK)2-TAT
klaklakklaklakGGRKKRRQRRR 1 1 1
d-DEK
GlldllelllkaaGw 3 3 1
d-DHK
GlldllhlllkaaGw 3 3 1
d-EEK
GllellelllkaaGw 3 3 1
D-FP21-PEG-PEI/pGRO-α
ytrdlvygdparpgiqgtgtf 1 1 1
D-K6L9
LKlLKKLlkKLLkLL 3 3 1
D-LA3IK
laiavk 4 4 1
D-LAK-120-A
kklalalakkwlalakklalalakk 4 4 1
D-melittin
gigavlkvlttglpaliswikrkrqqc 4 4 1
D-NAF-1
flgvlallgylavrpflpkkkqqk 1 1 1
D-RP-7
rppcvil 4 4 1
D-SVS-1
kvkvkvkvPptkvkvkvk 4 4 1
D2A21
FAKKFAKKFKKFAKKFAKFAFAF 7 6 1
D2A21V
VAKKFAKKFKKFAKKFAKFAFAF 4 3 1
DAP1
LWKRWVGVWRKWL 4 4 1
DC1
GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD 3 3 1
DC2
GAVPCGETCVYLPCITPDIGCSCQNKVCYRD 3 3 1
DC3
GTSCGETCVLLPCLSSVLGCTCQNKRCYKD 3 3 1
DDA-DL6K6-22
lKKllKKllKKl 2 2 1
DDA-DL6R6-25
DDAlRRllRRllRRl 2 2 1
DEE
GLLDLLELLLEAAGW 3 3 1
DEH
GLLDLLELLLHAAGW 3 3 1
DEK
GLLDLLELLLKAAGW 3 3 1
Demegen P-113
AKRHHGYKRKFH 2 2 1
Dermaseptin - B2
GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV 16 15 2
dermaseptin-PD-1
GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ 1 1 1
dermaseptin-PD-2
GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI 3 3 1
Dermaseptin-PH
ALWKEVLKNAGKAALNEINNLV 5 5 1
Dermaseptin-PP
ALWKDMLKGIGKLAGKAALGAVKTLV 5 4 2
Dermaseptin-PS1
ALWKTMLKKLGTVALHAGKAALGAVADTISQ 2 1 2
Dermaseptin-PS3
ALWKDILKNAGKAALNEINQIVQ 2 2 1
Dermaseptin-PS4
ALWKTLLKHVGKAAGKAALNAVTDMVNQ 5 5 1
Dermaseptin-PT9
GLWSKIKDAAKTAGKAALGFVNEMV 5 5 1
Dermaseptin-SS1
ALWKSILKNAGKAALNEINQIV 2 2 1
Dermaseptin-TO
ALWKDLLKNVGIAAGKAALNKVTDMVNQ 3 3 1
Dex-(KW)3
KWKWKW 2 2 1
DHE
GLLDLLHLLLEAAGW 3 3 1
DHH
GLLDLLHLLLHAAGW 3 3 1
DHK
GLLDLLHLLLKAAGW 3 3 1
DI
LTFEHYWAQLTS 2 1 1
di-PST13-RK-C
KKKFPWWWPFKKKCKKKFPWWWPFKKKC 2 2 1
di-PST13-RK-K
KKKFPWWWPFKKKKKKFPWWWPFKKKK 2 2 1
DIM-LF11-318
FWQRRIRRWRRFWQRRIRRWRR 3 2 2
DIM-LF11-322
PFWRIRIRRPFWRIRIRR 3 3 1
DIM-LF11-339
RRWFWRRRRWFWRR 3 3 1
Dimer of peptide-paclitaxel conjugate
(K-Aib-C(CH2CO-2'-Pac))4 3 3 1
DKE
GLLDLLKLLLEAAGW 3 3 1
DKH
GLLDLLKLLLHAAGW 3 3 1
DKK
GLLDLLKLLLKAAGW 3 3 1
DL6K6
lKKllKKllKKl 2 2 1
DL6R6
lRRllRRllRRl 2 2 1
dLL-37(17-32)c
FKRIVQRIKDFLRNLV 3 3 1
DLP-PH
NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN 2 2 1
DN1
ILGKIVKKLVSDF 1 1 1
DN4
ILGKIWKGIVSDF 1 1 1
DP-2
GRKKRRQRRRGALWKSLLKNVGKA 2 2 1
DP1
KLAKLAKKLAKLAK 1 1 1
DRS B3
ALWKNMLKGIGKLAGQAALGAVKTLVGA 1 1 1
DRS B4
ALWKDILKNVGKAAGKAVLNTVTDMVNQ 1 1 1
DRS S1
ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ 1 1 1
DRS-DU-1
ALWKSLLKNVGKAAGKAALNAVTDMVNQ 2 2 1
Dybowskin-2
FLIGMTQGLICLITRKC 1 1 1
E5
GGRSFFLLRRIQGCRFRNTVDD 4 4 2
EB(H2R)-lytic
YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK 6 6 1
EB-Lytic
YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK 6 6 1
EEE
GLLELLELLLEAAGW 3 3 1
EEH
GLLELLELLLHAAGW 3 3 1
EEK
GLLELLELLLKAAGW 3 3 1
EGFR-lytic
YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK 2 1 1
EGFR-related peptide
ERRP 1 1 1
EHE
GLLELLHLLLEAAGW 3 3 1
EHH
GLLELLHLLLHAAGW 3 3 1
EHK
GLLELLHLLLKAAGW 3 3 1
EKE
GLLELLKLLLEAAGW 3 3 1
EKH
GLLELLKLLLHAAGW 3 3 1
EKK
GLLELLKLLLKAAGW 3 3 1
Ep-AMP1
CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV 1 1 1
EP5-1
ACSAG 1 1 1
Epinecidin-1
GFIFHIIKGLFHAGKMIHGLV 31 2 1
Epinecidin-8
FIFHIIKGLFHAGKMI 40 2 1
ES-2
IVRRADRAAVP 3 1 1
F9D/A12D
KWKSFLKTfKSaKKTVLHTALKAISS 4 4 1
F9D/A12D/V16D
KWKSFLKTfKSaKKTvLHTALKAISS 4 4 1
FAGVL
FAVGLRAIKRALKKLRRGVRKVAKDL 7 6 1
FHV-2D5
RRRRNRTRRNRRRVRGGLTIYFY 1 1 1
Fi-Histin1-21
SRSSRAGLQFPVGRIHRLLRK 2 2 1
Figainin 1
FIGTLIPLALGALTKLFK 3 3 1
Figainin 2
FLGAILKIGHALAKTVLPMVTNAFKPKQ 2 2 1
Figanin 2BN
FLGVALKLGKVLGKALLPLASSLLHSQ 3 3 1
FKRLA
FKRLAKIKVLRLAKIKR 7 6 1
FLAG26-D1
FAKKLAKLAKKL 7 6 1
FLAG26-D3
FAKKLLAKALKL 7 6 1
FLAK 06R-AM
FAKKLAKKLKKLAKLALAK 7 6 1
FLAK 17 AM
FALALKKALKALKKAL 7 6 1
FLAK 17 C
FAKALKALLKALKAL 7 6 1
FLAK 17 CV
VAKALAKALLKALKAL 4 3 1
FLAK 25 AM
FAKKLAKLAKKLAKLALAL 7 6 1
FLAK 25 AM V
VAKKLAKLAKKLAKLALAL 4 3 1
FLAK 26 Ac
FAKKLAKLAKKLAKLAL 7 6 1
FLAK 26 AM
FAKKLAKLAKKLAKLAL 7 6 1
FLAK 50E
FAKLLKLAAKKLL 7 6 1
FLAK 50G
FAKLLAKLAKLKL 7 6 1
FLAK 50H
FAKLLAKLAKAKL 7 6 1
FLAK 50N
FAKLLAKALKLKL 7 6 1
FLAK 50O
FAKLLAKALKKAL 7 6 1
FLAK 50P
FAKLLAKALKKL 7 6 1
FLAK 54
FAKKLAKKLAKAL 7 6 1
FLAK 56
FAKKLAKKLAKLL 7 6 1
FLAK 58
FAKKLAKKLAKAAL 7 6 1
FLAK 72
FAKKLAKKAKLAKKL 7 6 1
FLAK 75
FAKKLKKLAKKL 7 6 1
Flak 96H
FALALKALKKA 7 6 1
Flak 96I
FALLKALLKKAL 7 6 1
Flak 96J
FALALKLAKKL 7 6 1
Flak 96L
LKKLAKLALAF 7 6 1
FLAK-120B
FALA 7 6 1
FLAK-120C
FALALKAKKL 7 6 1
FLAK-120D
FALALKLKKL 7 6 1
FLAK-120F
WALAL 7 6 1
FLAK-120G
VALALKALKKL 7 6 1
FLAK01 AM
FALAAKALKKLAKKLKKLAKKAL 7 6 1
FLAK03 AM
FALALKALKKLLKKLKKLAKKAL 7 6 1
FLAK04 AM
FALALKALKKLAKKLKKLAKKAL 7 6 1
FLAK04 AM V
VALALKALKKLAKKLKKLAKKAL 4 3 1
FLAK05 AM
FALAKLAKKAKAKLKKALKAL 7 6 1
FLAK06 AC
FALALKALKKLKKALKKAL 7 6 1
FLAK06 AM
FALALKALKKLKKALKKAL 9 6 1
FLAK06 R-AC
FAKKLAKKLKKLAKLALAL 5 5 1
FLAK100-CO2H
KLLKLLLKLYKKLLKLL 7 6 1
FLAK120
FALALKALKKL 7 6 1
FLAK121
FALAKALKKAL 7 6 1
FLAK26-D2
FAKKLAKLAKKLAKAL 7 6 1
FLAK26V AM
VAKKLAKLAKKLAKLAL 7 6 1
FLAK43 AM
FAKKLAKLAKKLLAL 7 6 1
FLAK43 AM V
VAKKLAKLAKKLLAL 4 3 1
FLAK44 AM
FAKKLAKLAKKALAL 7 6 1
FLAK50
FAKLLAKLAKKLL 7 6 1
FLAK50 Q1
FAKFLAKFLKKAL 7 6 1
FLAK50 Q10
FKLAFKLAKKAFL 7 6 1
FLAK50 Q1V
VAKFLAKFLKKAL 4 3 1
FLAK50 Q2
FAKLLFKALKKAL 7 6 1
FLAK50 Q3
FAKLLAKFLKKAL 7 6 1
FLAK50 Q4
FAKLLAKAFKKAL 7 6 1
FLAK50 Q5
FAKLFAKAFKKAL 7 6 1
FLAK50 Q6
FAKLLAKALKKFL 7 6 1
FLAK50 Q7
FAKLLAKALKKFAL 7 6 1
FLAK50 Q8
FAKLLAKLAKKFAL 7 6 1
FLAK50 Q9
FAKLFAKLAKKFAL 7 6 1
FLAK50 T1
FAKLLAKLAK 7 6 1
FLAK50 T2
FAKLLAKLAKKVL 7 6 1
FLAK50 T3
FAKLLAKLAKKIL 7 6 1
FLAK50 T4
FAKLLAKLAKKEL 7 6 1
FLAK50 T5
FAKLLAKLAKKSL 7 6 1
FLAK50 Z1
FGKGIGKVGKKLL 7 6 1
FLAK50 Z10
FAKIIAKIAKKI 7 6 1
FLAK50 Z2
FAFGKGIGKVGKKLL 7 6 1
FLAK50 Z3
FAKAIAKIAFGKGIGKVGKKLL 7 6 1
FLAK50 Z4
FAKLWAKLAFGKGIGKVGKKLL 7 6 1
FLAK50 Z5
FAKLWAKLAKKL 7 6 1
FLAK50 Z6
FAKGVGKVGKKAL 7 6 1
FLAK50 Z7
FAFGKGIGKIGKKGL 7 6 1
FLAK50 Z8
FAKIIAKIAKIAKKIL 7 6 1
FLAK50 Z9
FAFAKIIAKIAKKII 7 6 1
FLAK50B
FAKALAKLAKKLL 7 6 1
FLAK50C
FAKLLAKLAKKAL 7 6 1
FLAK50D
FAKLLAKALKKLL 7 6 1
FLAK50D V
VAKLLAKALKKLL 4 3 1
FLAK50F
FAKLLAKLAKKL 7 6 1
FLAK50I
FAKLLALALKLKL 7 6 1
FLAK50J
FAKLLAKLAKKAA 7 6 1
FLAK50K
FAKLLAKLAKAKA 7 6 1
FLAK50L
FAKLLAKLAKAKG 7 6 1
FLAK50T6
FAKLLAKLAKK 7 6 1
FLAK50T7
FAKLLAKLAKKGL 7 6 1
FLAK50T8
VAKLLAKLAKKVL 7 6 1
FLAK50T9
YAKLLAKLAKKAL 7 6 1
FLAK50V
VAKLLAKLAKKLL 7 6 1
FLAK51
FAKKLAKLALKLAKL 7 6 1
FLAK57
FAKKLAKKLAKLAL 7 6 1
FLAK62 AM
FALAKKALKKAKKAL 7 6 1
FLAK71
FAKKLKKLAKLAKKL 7 6 1
FLAK77
FAKKALKALKKL 7 6 1
FLAK80
FAKLLAKKLL 7 6 1
FLAK81
FAKKLAKALL 7 6 1
FLAK82
FAKKLAKKLL 7 6 1
FLAK83M
FAKLAKKLL 7 6 1
FLAK90
FAKLA 7 6 1
FLAK91
FAKLF 7 6 1
FLAK91B
FAKLAKKALAKLL 7 6 1
FLAK92
KAKLF 7 6 1
FLAK92B
KAKLAKKALAKLL 7 6 1
FLAK93
KWKLF 7 6 1
FLAK93B
KWKLAKKALALL 7 6 1
FLAK94
FALALKA 7 6 1
FLAK95
FALKALKKLKKALKKAL 7 6 1
FLAK96
FALALKALKKAL 7 6 1
FLAK96B
FALALKLAKKAL 7 6 1
FLAK96C
FALKALKKAL 7 6 1
FLAK96D
FALLKALKKAL 7 6 1
FLAK96F
FALALKALKK 7 6 1
FLAK96G
FALLKL 7 6 1
FLAK97
FALKALKK 7 6 1
FLAK98
KYKKALKKLAKLL 7 6 1
FLAK99
KLALKLALKALKAAKLA 7 6 1
FR-15
FRRFFKWFRRFFKFF 4 4 1
FR11P
FRRFFKWFRRPFKFF 4 4 1
FR4,8P
FRRPFKWPRRFFKFF 4 4 1
FR4P
FRRPFKWFRRFFKFF 4 4 1
FR8,11P
FRRFFKWPRRPFKFF 4 4 1
FR8P
FRRFFKWPRRFFKFF 4 4 1
Frenatin 2.1S
GLVGTLLGHIGKAILG 1 1 1
Frenatin 2.2S
GLVGTLLGHIGKAILS 1 1 1
GA - 2
Structure given in figure 2 2 1
GA - 3
Structure given in figure 2 2 1
GA - 4
Structure given in figure 2 2 1
GA - 5
Structure given in figure 2 2 1
GA - 7
Structure given in figure 3 3 1
GA - 8
Structure given in figure 2 2 1
GA-K3
FLGWLFKWAKK 14 7 1
GA-K4
FLKWLFKWAKK 14 7 1
GA-W3
FLGWLFKWAWK 14 7 1
GA-W4
FLWWLFKWAWK 14 7 1
Gaegurin peptides SEQID NO: 1
FLGWLFKWAKK 15 8 1
Gaegurin peptides SEQID NO: 2
FLKWLFKWAKK 16 8 1
Gaegurin peptides SEQID NO: 3
FLGWLFKWAWK 16 8 1
Gaegurin peptides SEQID NO: 4
FLWWLFKWAWK 16 8 1
Gageostatin A
ELLVDLL 6 6 1
Gageostatin B
ELLVDLL 6 6 1
Gageostatin C
ELLVDLL 6 6 1
Galaxamide
(N-Me-L)L(N-Me-L)LL 5 5 1
GE18
GAGIVVASIDTGVRVSHE 1 1 1
GGN6
FLPLLAGLAANFLPTIICKISYKC 5 4 1
GI-15
LC-Propargyl-GIIKKIIKKIIKKII 2 2 1
GM15
GGTCVIRGCVPKKLM 1 1 1
Gomesin
ZCRRLCYKQRCVTYCRGR 3 3 2
GP-1
FKEHGY 3 3 1
GP-2
EGFHL 3 3 1
GP-3
FSHTYV 3 3 1
Gramicidin A
VGAlAvVvWlWlWlW 1 1 1
GV1001
EARPALLTSRLRFIPK 1 1 1
H-0
IKLSPETKDNLKKVLKGAIKGAIAVAKMV 3 3 1
H-14
IKLSKKTKKNLKKVLKGAIKGAIAVAKMV 3 3 1
HAL-1
GMWSKILGHLIR 3 3 1
HAL-1/10
GMWKKILGKLIR 3 3 1
HAL-1/12
GKWSKILGHLIR 3 3 1
HAL-1/15
GMWSKLLGHLLR 3 3 1
HAL-1/17
KMWSKILGHLIR 3 3 1
HAL-1/18
GMWSKILKHLIR 3 3 1
HAL-1/19
GKWKKILGHLIR 3 3 1
HAL-1/20
GKWSKILGKLIR 3 3 1
HAL-1/21
GKWKKILGKLIR 3 3 1
HAL-1/22
gmwskilghlir 3 3 1
HAL-1/29
GMWSKILGHLIR 3 3 1
HAL-1/4
GMWSKILGHLKR 3 3 1
HAL-1/5
GMWKKILGHLIR 3 3 1
HAL-1/6
GMWSKILGHLIK 3 3 1
HAL-1/9
GMWSKILGKLIR 3 3 1
HAL-2
GKWMSLLKHILK 3 3 1
HAL-2/1
GKWKSLLKHILK 3 3 1
HAL-2/11
GKWLSLLKHILK 3 3 1
HAL-2/13
GKWMTLLKHILK 3 3 1
HAL-2/18
GKWMSLLKHIWK 3 3 1
HAL-2/19
GKWMSLLKHWLK 3 3 1
HAL-2/2
GKWMKLLKHILK 3 3 1
HAL-2/20
GKWMSLWKHILK 3 3 1
HAL-2/22
gkwmsllkhilk 3 3 1
HAL-2/24
GKFMSLLKHILK 3 3 1
HAL-2/4
GKWMSLLKKILK 3 3 1
HAL-2/6
GKWMSFLKHILK 3 3 1
HAL-2/8
GKWMSLLKHILK 3 3 1
Halictine 1
GMWSKILGHLIR 1 1 1
Halictine 2
GKWMSLLKHILK 1 1 1
HAZ
GVKFAKRFWRFAKKAFKRFEK 1 1 1
HB43
FAKLLAKLAKKLL 4 4 1
HB43-mut2
FAKLLAKLAKLLK 4 4 1
HB43-mut3
FAKLLAKLARRLL 4 4 1
hBD-1
DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK 1 1 1
hBD3-3
GKCSTRGRKCCRRKK 2 1 2
hBD3-3 M1
GKCSTRGRKCMRRKK 2 1 2
hBD3-3 M2
GKCSTRGRKMCRRKK 2 1 2
HCAP18(109-135)
FRKSKEKIGKEFKRIVQRIKDFLRNLV 1 1 1
HECATE 2DAc
FALALKALKKALkkLKKALKKAL 7 6 1
Hecate AC
FALALKALKKALKKLKKALKKAL 7 6 1
Hecate AC V
VALALKALKKALKKLKKALKKAL 4 3 1
Hecate AM
FALALKALKKALKKLKKALKKAL 7 6 1
Hecate AM V
VALALKALKKALKKLKKALKKAL 4 3 1
HEE
GLLHLLELLLEAAGW 3 3 1
HEH
GLLHLLELLLHAAGW 3 3 1
HEK
GLLHLLELLLKAAGW 3 3 1
Hepcidin
ICIFCCGCCHRSKCGMCCKT 1 1 1
hepcidin TH1-5
GIKCRFCCGCCTPGICGVCCRF 1 1 1
HHE
GLLHLLHLLLEAAGW 3 3 1
HHH
GLLHLLHLLLHAAGW 3 3 1
HHK
GLLHLLHLLLKAAGW 3 3 1
HHPHG
HHPHG 1 1 1
HIV-TAT48-57
GRKKRRQRRR 4 1 1
HKE
GLLHLLKLLLEAAGW 3 3 1
HKH
GLLHLLKLLLHAAGW 3 3 1
HKK
GLLHLLKLLLKAAGW 3 3 1
HM-10/10
LRKLRKRLLRLVGRQLEEFL 1 1 1
HMM-ID
AAEKEFIKYPYPTPLQYQQLATRLKVEKKLVRRW 1 1 1
HMP-S7
SFIPRAKSTWLNNIKLL 4 4 1
HN-1
FALGAVTKLLPSLLCMITRKC 6 6 1
HNP-1
ACYCRIPACIAGERRYGTCIYQGRLWAFCC 1 1 1
HNP-2
CYCRIPACIAGERRYGTCIYQGRLWAFCC 1 1 1
HNP-3
DCYCRIPACIAGERRYGTCIYQGRLWAFCC 1 1 1
hP1
HSHRDFQPVLHLVALNSPLSGGMRG 1 1 1
hP2
MRGIRGADFQAFQQARAVGLAGTFR 1 1 1
hP3
TFRAFLSSRLQDLYSIVRRADRAAV 1 1 1
hP4
AAVPIVNLKDELLFPSWEALFSGSE 1 1 1
hP5
GSEGPLKPGARIFSFDGKDVLRHPT 1 1 1
hP6
HPTWPQKSVWHGSDPNGRRLTESY 1 1 1
hP7
ETWRTEAPSATGQASSLLGGRLLGQ 1 1 1
hP8
LGQSAASAHHAYIVLAIENSFMTASKKK 1 1 1
HPRP-A1
FKKLKKLFSKLWNWK 6 6 1
HPRP-A1-TAT
FKKLKKLFSKLWNWKRKKRRQRRR 4 4 1
HR
HVLSRAPR 4 4 1
HTDT-6-2-3-2
GPLGAGP 3 3 1
HTLV-II-Rex-2D5
TRRQRTRRARRNRGGLTIYFY 1 1 1
Human neutrophil peptide-1 (HNP-1)
ACYCRIPACIAGERRYGTCIYQGRLWAFCC 1 1 1
HX-12A
FFRKVLKLIRKI 1 1 1
HX-12B
FFRKVLKLIRKIF 1 1 1
HX-12C
FFRKVLKLIRKIWR 1 1 1
Hymenochirin - 1B
IKLSPETKDNLKKVLKGAIKGAIAVAKMV 4 4 1
IDP-La05
RRNDLRSRFLALRDQVP 3 3 1
IDP-Lb01
SKAPKVVILSKALEYL 3 3 1
IDP-Lb02
SKAPKVVILSKALEYL 3 3 1
IDP-Lb03
SKAPKVVILSKALEYL 3 3 1
IDP-Lb04
SKAPKVVILSKALEYL 3 3 1
IDP-Lb05
SKAPKVVILSKALEYL 3 3 1
IDP-Lb06
SKAPKVVILSKALEYL 3 3 1
IDP-LLCb01
RRRRRRRSKAPKVVILSKALEYLQA 3 3 1
IDP-LLCb02
RQIKWFQNRRMKWKKSKAPKVVILSKALEYLQA 3 3 1
IDP-LS05
RKRRNDLRSRFLALRDQ 2 2 1
IDP-LS13
RKRRNDLRSRFLALRDQ 4 4 1
IDP-LS15
RKRRNDLRSRFLALRDQ 2 2 1
IDP-LS16
APKVVILSKALEYLQA 2 2 1
IDP-LS17
APKVVILSKALEYLQA 2 2 1
IDP-Na05
RRNDLRSSFLTLRDHVP 1 1 1
IDP-NLCa02
RQIKIWFQNRRMKWKKRQRRNDLRSSFLTLRDHVP 1 1 1
IDP-NS02
RQRRNDLRSSFLTLRDH 1 1 1
IDP-NS10
AALVVILKKATEYVHS 8 8 1
IDP-NS16
RQRRNDLRSSFLTLRDH 2 2 1
IDP-wtL05
RKRRNDLRSRFLALRDQ 1 1 1
IK13
CIIKKIIKKIIKK 2 2 1
IL-1
FKAGGFIKKLWRSLLA 3 2 2
IL-2
FKIGGFAKKLWRSLLA 3 2 2
IL-3
FKIGGFIKKAWRSLLA 3 2 2
IL-4
FKIGGFIKKLWRSALA 3 2 2
IL-4RaÐlytic hybrid peptide
KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK 7 7 1
IL-5
FKIGGFIKKLWRSLAA 3 2 2
IL13Rα2 D1 peptide
GSETWKTIITKN 4 4 1
Indolicidin
ILPWKWPWWPWRR 7 6 1
Indolicidin-Arg
ILPWKWPWWPWRR 1 1 1
Indolicidin-Lys
ILPWKWPWWPWKK 1 1 1
Indolocidin-ac
ILPWKWPWWPWRR 7 6 1
IR13
CIIRRIIRRIIRR 2 2 1
IturinA
NYNQPNS 4 4 1
Jeff-[G10a]2-SHa
FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF 6 6 1
K14D
KWKSFLKTFKSAKkTVLHTALKAISS 4 4 1
K14D/T15D
KWKSFLKTFKSAKktVLHTALKAISS 4 4 1
K2-NH2
UKLUGGLUGI 1 1 1
K25-Lol
UKLUKGLUGI 1 1 1
K2569-Lol
UKLUKKLUKI 1 1 1
K259-Lol
UKLUKGLUKI 1 1 1
K259-NH2
UKLUKGLUKI 1 1 1
K2F6K2
KKFFFFFFKK 1 1 1
K3F6K3
KKKFFFFFFKKK 1 1 1
K4F6K4
KKKKFFFFFFKKKK 2 1 2
K4F8K4
KKKKFFFFFFFFKKKK 1 1 1
K4R2-Nal2-S1
KKKKRR-Nal-Nal-KKWRKWLAKK 6 6 1
K5, 17-DPS3
ALWKKILKNAGKAALNKINQIVQ 2 2 1
K56-Lol
UGLUKKLUGI 1 1 1
K6-Nal2-S1
KKKKKK-Nal-Nal-KKWRKWLAKK 6 6 1
K6-NH2
UGLUGKLUGI 1 1 1
K8, 23-DPT9
GLWSKIKKAAKTAGKAALGFVNKMV 5 5 1
KAL V
VALALKALKKALKKLKKALKKAL 7 6 1
Kassiniatuerin-3
FIQHLIPLIPHAIQGIKDIF 6 6 1
KEE
GLLKLLELLLEAAGW 3 3 1
KEH
GLLKLLELLLHAAGW 3 3 1
KEK
GLLKLLELLLKAAGW 3 3 1
KEMTUB10
Str given in figure 5 5 1
KHE
GLLKLLHLLLEAAGW 3 3 1
KHH
GLLKLLHLLLHAAGW 3 3 1
KHK
GLLKLLHLLLKAAGW 3 3 1
KilerFLIP
YGRKKRRQRRRREADFFWSLCTADMS 1 1 1
KKE
GLLKLLKLLLEAAGW 3 3 1
KKH
GLLKLLKLLLHAAGW 3 3 1
KKK
GLLKLLKLLLKAAGW 3 3 1
KM8
KLLKINLKALAALAKKIL 1 1 1
KM8-Aib
KLLKINLK(Aib)LAALAKKIL 1 1 1
KSL-1
KKVVFKVKFK 7 6 1
KSL-7
FKVKFKVKVK 7 6 1
KT2
NGVQPKYKWWKWWKKWW 3 3 2
KW5
KAAKKAAKAAKKAAKAAKKAA 2 2 1
L-Carnosine
Beta-AH 3 3 1
L-FP21-PEG-PEI/pGRO-α
YTRDLVYGDPARPGIQGTGTF 1 1 1
L-K6
IKKILSKIKKLLK 1 1 1
L. squarrosulus purifed fraction
RYGFTEVAGNFQQHNFGRG 1 1 1
L1
PEWFKCRRWQWRMKKLGA 3 3 1
L10
PAARKAFRWAWRMLKKAA 3 3 1
L10, 11-DPS3
ALWKDILKNLLKAALNEINQIVQ 2 2 1
L11
PAARKAARWAWRMLKKGA 3 3 1
L12
PAWRKAFRWAKRMLKKAA 3 3 1
L13
PAWRKAFRKAWRMLKKAA 3 3 1
L14
PAWRKARRWAWRMKKLAA 5 5 2
L15
PAWRKARRWARRMKKLAA 3 3 1
L17A
KWKSFLKTFKSAKKTVAHTALKAISS 8 8 1
L17A/L21A
KWKSFLKTFKSAKKTVAHTAAKAISS 8 8 1
L2
PAWFKARRWAWRMKKLAA 3 3 1
L21A
KWKSFLKTFKSAKKTVAHTAAKAISS 8 8 1
L2V
ALWKSILKNVGKVLNEINQIVQ 2 2 1
L3
PAWRKAFRWAWRMKKLAA 3 3 1
l3,10,13K7,8K4R2L9
KLlRLLkkLlRLlLK 2 2 1
l3,4,8,10K5L7
KLllKLKlKlLK 2 2 1
L4
PAWFKARRWAWRMLKKAA 3 3 1
L5
PAWRKAFRWAWRMLKKAA 3 3 1
L6
PAWRKAFRWAARMLKKAA 3 3 1
L6A
KWKSFAKTFKSAKKTVLHTALKAISS 8 8 1
L6A/L17A
KWKSFAKTFKSAKKTVAHTALKAISS 8 8 1
L7
PAWRKAFRAAWRMLKKAA 3 3 1
L8
PAWAKAFRAAARMKLKAA 3 3 1
L8H6
LHHLLHLLHHLLHL 1 1 1
L9
PAWRKAARWAWRMLKKAA 3 3 1
L9H5-1
LHLLLHLLHHLLHL 1 1 1
LA-C1b
SKVWRHWRRFWHRAHRLH 3 3 1
LA3IK
LAIAVK 4 4 1
LA3IK-SCR
LAKAVI 4 4 1
Lactoferricin B
FKCRRWQWRMKKLGA 5 5 1
Lan-7
fA*YwKA*T 6 4 1
Lasioglossin - III
VNWKKILGKIIKVVK 2 2 1
Latarcin 2a
GLFGKLIKKFGRKAISYAVKKARGKH 1 1 1
Laxaphycin A
Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG 3 3 1
Laxaphycin B
A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu 7 3 1
LCP-1
FHVL 4 4 1
LCP-2
WAHT 4 4 1
LCP-3
WHLV 4 4 1
Leu4-NH2
UGLLGGLUGI 1 1 1
LFampin265–284
DLIWKLLSKAQEKFGKNKSR 2 2 1
LFB
GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC 9 6 2
LFchimera
FKCRRWQWRMKKLG-K-RSKNKGFKEQAKSLLKWILD 2 2 1
LFcin17–30
FKCRRWQWRMKKLG 2 2 1
LfcinB
FKCRRWQWRMKK 12 11 1
LfcinB (21-25)Pal
RWQWRWQWR 3 3 1
LfcinB(21-25)Pal
RWQWRWQWR 3 3 1
LfcinB-P13
KCRRWLKRMKKLG 1 1 1
linear (RW)4-Dox
RWRWRWRW 4 4 1
Lipotetrapeptide-C16-PCatPCatPCatPCat-NH2
PcatPhexPhexPcat 4 4 1
LJP-1
EGFHL 3 3 1
LJP-10
HASWEH 3 3 1
LJP-11
YEHSHG 3 3 1
LJP-12
TFKHG 3 3 1
LJP-2
LWEHSH 3 3 1
LJP-3
FSHRGH 2 2 1
LJP-4
EGHGF 3 3 1
LJP-5
FSTHGG 3 3 1
LJP-6
FKEHGY 1 1 1
LJP-7
HAGYSWA 3 3 1
LJP-8
FSHTYV 3 3 1
LJP-9
FEHSG 3 3 1
LK-LE1
CLKKLLKLLKKLLKLCLHELLEHLHELLEH 1 1 1
LK-LE2
CLKKLLKLLKKLLKLCLEHLLEHLEHLLEH 1 1 1
LK-LE3
CLKKLLKLLKKLLKLCLEELLHHLEELLHH 1 1 1
LK13
CLLKKLLKKLLKK 2 2 1
LL 37
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES 3 3 1
LL-37 Analogue 1
FKRIVQRIKDFLR 1 1 1
LL-37 Analogue 10
FKRIVQLIKDFLR 1 1 1
LL-37 Analogue 11
FKRIVQRIKDLLR 1 1 1
LL-37 Analogue 12
FKRIVQRIKDLLR 1 1 1
LL-37 Analogue 13
FKRIVQIIKKFLR 1 1 1
LL-37 Analogue 14
FKRIVQIIKKFLR 1 1 1
LL-37 Analogue 15
FKRIVQLLKKLLR 1 1 1
LL-37 Analogue 16
FKRIVQLLKKLLR 1 1 1
LL-37 Analogue 17
FKRILQRIKDFLR 1 1 1
LL-37 Analogue 18
FKRILQRIKDFLR 1 1 1
LL-37 Analogue 2
LKRIVQRIKDFLR 1 1 1
LL-37 Analogue 3
AKRIVQRIKDFLR 1 1 1
LL-37 Analogue 4
FΚRIVQRILDFLR 1 1 1
LL-37 Analogue 5
FKSARIVQRILDFLR 1 1 1
LL-37 Analogue 6
FKRIVQRIRDFLR 1 1 1
LL-37 Analogue 7
FKRIVQRIRDFLR 1 1 1
LL-37 Analogue 8
FKRIVQKIKDFLR 1 1 1
LL-37 Analogue 9
FKRIVQLIKDFLR 1 1 1
LL-37(1-12)
LLGDFFRKSKEK 3 3 1
LL-37(1-4,17-27)
LLGDFKRIVQRIKDF 3 3 1
LL-37(13-37)
IGKEFKRIVQRIKDFLRNLVPRTES 3 3 1
LL-37(17-29)
FKRIVQRIKDFLR 3 3 1
LL-37(17-32)b
FKRIVQRIKDFLRNLV 3 3 1
LL-III
VNWKKILGKIIKVVK 3 3 1
LL-III/1
VNWKKILAKIIKVVK 3 3 1
LL-III/10
KNWKKILGKIIKVVK 3 3 1
LL-III/11
VNWKKIILGKIIKVVK 3 3 1
LL-III/12
vnwkkilgkiikvvk 3 3 1
LL-III/15
VNFKKLLGKLLKVVK 3 3 1
LL-III/16
VN-Nal-KKLLGKLLKVVK 3 3 1
LL-III/17
VNWRRILGRIIRVVR 3 3 1
LL-III/18
KNWKKILKKIIKVVK 3 3 1
LL-III/19
VNWKK-Aib-LGK-Aib-IK-Aib-VK 3 3 1
LL-III/2
NVWKKILGKIIKVVK 3 3 1
LL-III/22
KNWKK-Aib-LKK-Aib-IK-Aib-VK 3 3 1
LL-III/23
VNWKKLLGKLLKVVK 3 3 1
LL-III/24
VNWOOILGOIIOVVO 3 3 1
LL-III/25
vnwkkllgkllkvvk 3 3 1
LL-III/26
VYWKKILGKIIKVVK 3 3 1
LL-III/27
VNWKKVLGKVVKVVK 3 3 1
LL-III/3
VNWKKILKKIIKVVK 3 3 1
LL-III/34
NKWKKILGKIIKVVK 3 3 1
LL-III/36
VNWKKILAKIIKVVK 3 3 1
LL-III/37
VNWKKILGKIIKVVK 3 2 1
LL-III/4
VNWKKILGKIKKVVK 3 3 1
LL-III/6
VNWKKILPKIIKVVK 3 3 1
LL-III/8
VNWKKILGKIIKVVK 3 3 1
LL-III/9
VNWKKILGKIIKVVK 3 3 1
Longicalycinin A
FYPFG 5 4 1
Longicalycinin A (Linear)
FYPFG 2 2 1
Longicalycinin A Cyclic analogue 1
GYPFV 4 2 1
Longicalycinin A cyclic analogue 10
FYPFA 4 2 1
Longicalycinin A cyclic analogue 11
TVPFA 4 2 1
Longicalycinin A cyclic analogue 12
FYPFI 4 2 1
Longicalycinin A cyclic analogue 13
VTPFL 4 2 1
Longicalycinin A cyclic analogue 14
PYFFL 4 2 1
Longicalycinin A cyclic analogue 15
PYGFV 4 2 1
Longicalycinin A cyclic analogue 16
FTPFV 4 2 1
Longicalycinin A cyclic analogue 17
FSPFA 4 2 1
Longicalycinin A cyclic analogue 18
FSPAG 4 2 1
Longicalycinin A cyclic analogue 3
GYPFA 4 2 1
Longicalycinin A cyclic analogue 4
AYPFG 4 2 1
Longicalycinin A cyclic analogue 5
FSPFG 4 2 1
Longicalycinin A cyclic analogue 6
VYPIA 4 2 1
Longicalycinin A cyclic analogue 7
PYVFA 4 2 1
Longicalycinin A cyclic analogue 8
FYPVG 4 2 1
Longicalycinin A cyclic analogue 9
FYPFV 4 2 1
Longicalycinin A linear analogue 1
GYPFV 4 2 1
Longicalycinin A linear analogue 10
FYPFA 4 2 1
Longicalycinin A linear analogue 11
TVPFA 4 2 1
Longicalycinin A linear analogue 12
FYPFI 4 2 1
Longicalycinin A linear analogue 13
VTPFL 4 2 1
Longicalycinin A linear analogue 14
PYFFL 4 2 1
Longicalycinin A linear analogue 16
FTPFV 4 2 1
Longicalycinin A linear analogue 17
FSPFA 4 2 1
Longicalycinin A linear analogue 18
FSPAG 4 2 1
Longicalycinin A linear analogue 2
LYPFA 4 2 1
Longicalycinin A linear analogue 3
GYPFA 4 2 1
Longicalycinin A linear analogue 4
AYPFG 4 2 1
Longicalycinin A linear analogue 5
FSPFG 4 2 1
Longicalycinin A linear analogue 6
VYPIA 4 2 1
Longicalycinin A linear analogue 7
PYVFA 4 2 1
Longicalycinin A linear analogue 8
FYPVG 4 2 1
Longicalycinin A linear analogue 9
FYPFV 4 2 1
Loop1-HCoV-229E
FKPQSGGGKCF 1 1 1
Loop1-PS2Aa
NNETYFNAVKP 2 2 1
Loop2-PS2Aa
TYFNAVKPPITA 2 2 1
LPSBD-0
CQYSVNPKIKRFELYFKGRMW 3 3 2
LPSBD-2
CHYRVKPKIKRFEKYKGRMW 3 3 2
LR13
CLLRRLLRRLLRR 2 2 1
LSB-37
LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG 7 6 1
Lt-MAP2
LIKKLKEYLKKLI 2 2 1
ltc2aG11A
GLFGKLIKKFARKAISYAVKKARGKH 1 1 1
LTX-302
WKKW-Dip-KKWK 3 3 1
LTX-315
KKWWKKW-Dip-K 6 6 1
LTX-318
OOW-Dip-OOWWO 3 3 1
LTX-328
KAQ-Dip-QKQAW 1 1 1
Lunatusin
KTCENLADTFRGPCFATSNC 1 1 1
LvHemB1
DVNFLLHKIYGNIRY 4 4 1
LVTX-8
IWLTALKFLGKNLGKHLAKQQLSKL 2 2 1
LVTX-9
ASIGALIQKAIALIKAKAA 1 1 1
LVTX-9-C18
ASIGALIQKAIALIKAKAA 4 4 1
LyeTx-I-b
IWLTALKFLGKNLGKLAKQQLAKL 4 4 2
LyeTxI-b
IWLTALKFLGKNLGKLAKQQLAKL 3 3 1
Lytik
KLlLKlLkkLLKlLKKK 19 18 1
M1-20
grrrqrrkkrlgpfsidllikslsdnmtdl 6 6 1
M1-21
rrrqrrkkrg-QTQPRLGPPQTPAGGCSILIF 8 8 1
MA-DL6K6-23
lKKllKKllKKl 2 2 1
MAC1
GFGMALKLLKKVL 3 3 1
MAC1/1
gfgmalkllkkvl 3 3 1
MAC1/10
GFKMALKLLKKVL 3 3 1
MAC1/16
GFGMALKLLKKVL 3 3 1
MAC1/19
GFGMALKLLKKVL 3 3 1
MAC1/2
AFGMALKLLKKVL 3 3 1
MAC1/20
GFGMALOLLOOVL 3 3 1
MAC1/21
GFGMALRLLRRVL 3 3 1
MAC1/24
GFGMALKL-(AC6C)-KKVL 3 3 1
MAC1/25
GFGMALK-(AC6C)-LKKVL 3 3 1
MAC1/26
GFGMA-(AC6C)-KLLKKVL 3 3 1
MAC1/3
LFGMALKLLKKVL 3 3 1
MAC1/4
GFGMALKLLKKVL 3 3 1
MAC1/6
GFGMALKLLKKVL 3 3 1
MAC1/9
GFKMALKLLKKVL 3 3 1
MAC2
GTGLPMSERRKIMLMMR 3 3 1
macrocyclic pyridoheptapeptide derivative 1a
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 1b
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 1c
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 2a
Structure given in Scheme 1 1 1 1
macrocyclic pyridoheptapeptide derivative 2b
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 2c
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 3a
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 3b
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 3c
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 4a
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 4b
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 4c
Structure given in Scheme 1 2 2 1
macrocyclic pyridoheptapeptide derivative 5a
Structure given in Scheme 1 1 1 1
macrocyclic pyridoheptapeptide derivative 5b
Structure given in Scheme 1 1 1 1
macrocyclic pyridoheptapeptide derivative 5c
Structure given in Scheme 1 1 1 1
Macropin 1
GFGMALKLLKKVL 1 1 1
Macropin 2
GTGLPMSERRKIMLMMR 1 1 1
Maculatin 1.1
GLFVGVLAKVAAHVVPAIAEHF 1 1 1
Maculatin 1.2
GLFVGLAKVAAHNNPAIAEHFQA 1 1 1
Maculatin 1.3
GLLGLLGSVVSHVVPAIVGHF 1 1 1
Maculatin 1.4
GLLGLLGSVVSHVLPAITQHL 1 1 1
Maculatin 2.1
GFVDFLKKVAGTIANVVT 1 1 1
Maculatin 3.1
GLLQTIKEKLESLESLAKGIVSGIQA 1 1 1
MAD1
KRWHWWRRHWVVW 3 3 1
Magainin 2
GIGKFLHSAKKFGKAFVGEIMNS 21 15 5
Magainin A
AIGKFLHSAKKFGKAFVGEIMNS 16 16 2
Magainin B
GIGKFLHAAKKFAKAFVAEIMNS 10 10 1
Magainin G
GIGKFLHSAKKFAKAFVAEIMNS 16 16 2
Magainin2wisc
GIGKFLHAAKKFAKAFVAEIMNS 7 6 1
MagaininF5W-Arg
GIGRWLHSARRFGRAFVGEIMNS 1 1 1
MagaininF5W-Lys
GIGKWLHSAKKFGKAFVGEIMNS 1 1 1
MAP-04-03
KWLRRVWRWWR 6 1 1
MAP-04-04
KRLRRVWRRWR 3 1 1
Mastoparan
INLKALAALAKKIL 1 1 1
Mastoparan B
LKLKSIVSWAKKVL 1 1 1
Mastoparan-C
LNLKALLAVAKKIL 5 5 1
Maximin 1
GIGTKILGGVKTALKGALKELASTYAN 1 1 1
Maximin 3
GIGGKILSGLKTALKGAAKELASTYLH 1 1 1
Maximin 4
GIGGVLLSAGKAALKGLAKVLAEKYAN 1 1 1
Maximin H1
ILGPVISTIGGVLGGLLKNL 1 1 1
Maximin H5
ILGPVLGLVSDTLDDVLGIL 1 1 1
maximin1
GIGTKILGGVKTALKGALKELASTYAN 4 4 1
maximin3
GIGGKILSGLKTALKGAAKELASTYLH 4 4 1
maximin4
GIGVLLSAGKAALKGLAKVLAEKYAN 4 4 1
maximin5
SIGAKILGGVKTFFKGALKELASTYLQ 4 4 1
MB30
GQVWEATATVNAIRGSVTPAVSQFNARTAD 36 6 1
MccJ25-18-4
GGAGHVPEYFVGIGTPISFYG-WxEAAYQrFL 3 3 1
MC–FA
GIGAVLKVLTTGLPALISWIKRKRQQC 3 3 1
Mel-C
GIGAVLKVLTTGLPALISWIKRKRQQC 3 3 1
MEL-Pep
GIGAVLKKLTTGLKALISWIKRKRQQ 1 1 1
Mela3
GKPICGETCFKGKCYTPGCTCSYPICKKD 2 2 1
MELITTIIN
GIGAVLKVLTTGLPALISWIKRKRQQ 7 6 1
Melittin
GIGAVLKVLTTGLPALISWIKRKRQQ 10 2 2
Mellitin
GIGAVLKVLTTGLPALISWIKRKRQQ 1 1 1
MG2d
GIGKFLHSAKKWGKAFVGQIMNC 1 1 1
MIP
PRFWEYWLRLME 2 1 1
MIP(F3A)
PRAWEYWLRLME 1 1 1
MIP(L10A)
PRFWEYWLRAME 1 1 1
MIP(M11A)
PRFWEYWLRLAE 1 1 1
MIP(R9A)
PRFWEYWLALME 1 1 1
MIP(W7A)
PRFWEYALRLME 1 1 1
MIP(Y6A)
PRFWEAWLRLME 1 1 1
MIPP
SLSLSVAR 1 1 1
Modelin-5
KLAKKLAKLAKLAKAL 7 6 1
Modelin-5-CO2H
KLAKKLAKLAKLAKAL 7 6 1
Modelin-8D
KFKKLAKKF 7 6 1
Modelin-8E
KFKKLAKKW 7 6 1
MP1-Q12K
IDWKKLLDAAKLIL 1 1 1
MP12
MDNHVCIPLCPP 1 1 1
mPep1
RKAFRWAWRMLKKAAPSITCVR 1 1 1
MPG
GALFLGFLGAAGSTMGAWSQPKKKRKV 1 1 1
mPNC-NLS
QETFSDLWKLLVQRKRQKLMP 3 2 2
Mra30
GIPCGESCVFIPCLTSAIGCSCKSKVCYRN 3 3 1
Mram 8
GIPCGESCVFIPCLTSAIDCSCKSKVCYRN 1 1 1
MSI-136
GIGKFLKKAKKFAKAFVKIINN 1 1 1
MSI-238
gigkflkkakkfakafvkiinn 1 1 1
MSI-78 AM
GIGKFLKKAKKFGKAFVKILKK 7 6 1
MSP-4
FIHHIIGGLFSAGKAIHRLIRRRRR 1 1 1
mtp1
DGDWDAWTRETS 3 3 1
mt_E17L/L22 W/P27A
LTFSDWWKLLAE 1 1 1
mt_L22 W/P27A
ETFSDWWKLLAE 1 1 1
mt_S20A/L22 W/P27A
ETFADWWKLLAE 1 1 1
mt_T18S/L22 W/P27A
ESFSDWWKLLAE 1 1 1
myristoyl-CM4
GRWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI 3 3 1
MzDef
MSSSNCANVCQTENFPGGECKAEGATRKCFCKNC 3 3 1
N-1
WKLFKKIPKFLHLAKKF 3 3 1
N-2
FKLFKKIPKFLHLAKKF 3 3 1
N-3
KWFKKIPKFLHLAKKF 3 3 1
N-3L
KWFKKIPKFLHLLKKF 3 3 1
N-4
WFKKIPKFLHLAKKF 3 3 1
N-4L
WFKKIPKFLHLLKKF 3 3 1
N-5
WKKIPKFLHLAKKF 3 3 1
N-5L
WKKIPKFLHLLKKF 3 3 1
N-Ter
RDVFTKGYGFGL 1 1 1
N-Ter-TAT
RDVFTKGYGFGL-GRK(Dansylglycine)KRRQRRRPQ 1 1 1
N29D
PDEDAINDALNKVCSTGRRQRSICKQLLKK 12 3 1
N29N
PDEDAINNALNKVCSTGRRQRSICKQLLKK 12 3 1
NAF-1
FLGVLALLGYLAVRPFLPKKKQQK 1 1 1
Nal2-S1
Nal-Nal-KKWRKWLAKK 6 6 1
Nigrocin-M1
GLLGKILGAGKKVLLGVSGLL 4 4 1
Nigrocin-PN
GLLGKILGAGKKVLCGVSGLC 3 3 1
Nisin Z
ITSISLCTPGCKTGALMGCNMKTATCNCSIHVSK 3 2 2
Nisin ZP
ITSISLCTPGCKTGALMGCNMKTATCNCSIHVSK 2 2 1
NK-11
KISKRILTGKK 5 1 1
NK-2
KILRGVCKKIMRTFLRRISKDILTGKK 13 5 2
NK-dpro
KILpGVCKKIMRpFLRRISKDILTGKK 4 4 1
NK-pro
KILRGVCKKIMRpFLRRISKDILTGKK 4 4 1
NK11
KISKRILTGKK 4 1 1
NKL-MUT
KLKSKLMVVANKIGLLKSLARKFVKSH 1 1 1
NKL-WT
KLKSKLMVVCNKIGLLKSLCRKFVKSH 1 1 1
NMANF2
KAIGLVIPEIDGKLDGGAQRV 2 2 1
NMTP-5
zffygwyggmekllrggrgerppr 1 1 1
NN-32
LKCNKLVPLF 6 2 3
NRC-03
GRRKRKWLRRIGKGVKIIGGAALDHL 24 9 2
NRC-07
RWGKWFKKATHVGKHVGKAALTAYL 24 7 2
NRC-13
GWRTLLKKAEVKTVGKLALKHYL 21 7 1
NT-10
RRPAIL 1 1 1
NT-11
RRPYAL 1 1 1
NT-12
PEGKRPY-Tle-L 3 1 1
NT-9
RRPYIL 1 1 1
NTP-217
KKWWKKW-Dip-K 6 6 1
OA-C1b
SKVWRHWRRFWHRAHRLH 3 3 1
Ocellatin-3N
GIFDVLKNLAKGVITSLAS 3 3 1
Odorranain-C1
GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC 4 4 1
oligopeptide 1
AGAPGG 1 1 1
oligopeptide 2
AERQ 1 1 1
oligopeptide 3
RDTQ 1 1 1
Omiganan MBI-226
ILRWPWWPWRRK 2 1 1
P
KWKSFLKTFKSAKKTVLHTALKAISS 8 8 1
P01
SETAPAAPAAPAPAEK 2 2 1
P02
AEEYEFLTPMEEAPK 2 2 1
P03
HVFGESDELIGQK 2 2 1
P04
IGEHTPSALAIMENANVLAR 2 2 1
P05
ADDGRPFPQVIK 2 2 1
P06
GAGTGGLGLAVEGPSEAK 2 2 1
P07
VEPGLGADNSVVR 2 2 1
P08
NSNLVGAAHEELQQSR 2 2 1
P09
AAGTLYTYPENWR 2 2 1
P1
KWKLFKKIGIGAVLKVLKKG 3 3 1
P10
FAAATGATPIAGR 2 2 1
P18
KWKLFKKIPKFLHLAKKF 13 5 1
P18-1
PIPYPIF 2 2 1
P18-2
PIPRPIF 2 2 1
P1A
YKSIEFC 1 1 1
P1B
YKSVEFC 1 1 1
P1C
YKSIEFC 1 1 1
P2
KWKLFKKIGIGKFLHSATTF 6 6 2
P264-G274
PARDVLNTTSG 2 2 1
p28
LSTAADMQGVVTDGMASGLDKDYLKPDD 2 2 1
P3
KWKLFKKIGIGAFLHSAKKF 3 3 1
p369-CTL-A2xFVB
KIFGSLAFL 5 1 1
p369-CTL-A2xneu
KIFGSLAFL 5 1 1
P4
KWKLFKKIGIGKFLHLAKKF 3 3 1
P5
KWKLFKKIGIGAFLHLAKKF 3 3 1
P5317-28
QETFSDLWKLLP 2 1 1
P6
WYIRKIRRFFKWLKKKLKKK 8 8 2
P7
KWKLFAKIGIGKFLHLAKKF 4 4 2
p776
GVGSPYVSRLLGICL 1 1 1
P8
KWKKFLKIGIGKFLHLAKKF 3 3 1
p85
LIAHNQVRQV 1 1 1
PA-C1b
SKVWRHWRRFWHRAHRLH 3 3 1
PA-DL6K6-24
lKKllKKllKKl 2 2 1
PACAP38
HSDGIFTDSYSRYRKQMAVKKYLAAVLGRRYRQRFRNK 1 1 1
Pal-pFL-N-Ter-TAT
FPWWWPFLRDVFTKGYGFGLGRKKRRQRRRPQ 3 3 1
Palustrin - Ca
GFLDIIKDTGKEFAVKILNNLKCKLAGGCPP 1 1 1
Pantinin-1
GILGKLWEGFKSIV 2 2 1
Pantinin-2
IFGAIWKGISSLL 2 2 1
Pantinin-3
FLSTIWNGIKSLL 2 2 1
Pardaxin
GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE 5 2 2
Pardaxin-1
GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE 36 2 1
Pardaxin-6
GFFALIPKIISSPLFKTLLSAVGSALS 40 2 1
PCC-1
KKRKKKAFALKFVVDLI 2 2 1
PCK3145
PGDSTRKCMDLKGNK 1 1 1
Pep
GKLRLIKKLWVKKWKKKGWKA 2 2 1
Pep-1-Phor21
CGEMGWVRCKFAKFAKKFAKFAKKFAKFAK 3 3 1
pep1
FKCRRWQWRMKKLGAPSITCVR 1 1 1
Pep27
MRKEFHNVLSSGQLLADKRPARDYNRK 5 5 1
Pep27anal1
MWKWFHNVLSSWQLLADKRPARDYNRK 5 5 1
Pep27anal2
MWKWFHNVLSWWWLLADKRPARDYNRK 5 5 1
Pep27anal3
MRKWFHNVLSSGQLLADKWPAWDYNRK 5 5 1
Pep27anal4
MWKEFHNVLSSGQLLADKRWARWYNRW 5 5 1
Pep27anal5
MWKWFHNVLSSGQLLADKWWAWWYNWW 5 5 1
Peptide 1a
FE 4 4 1
Peptide 1b
WD 1 1 1
Peptide 2a
YE 3 3 1
Peptide 2b
PE 4 4 1
Peptide 3a
YD 3 3 1
Peptide 3b
YD 2 2 1
Peptide 4a
HE 1 1 1
Peptide 4b
HD 4 4 1
Peptide 5a
HD 1 1 1
Peptide 5b
FE 3 3 1
Peptide 6a
WD 3 3 1
Peptide 6b
FD 3 3 1
Peptide 7a
PD 3 3 1
Peptide 7b
PD 3 3 1
Peptide K14D
KWKSFLKTFKSLKkTVLHTLLKAISS 1 1 1
Peptide K14D/K22D
KWKSFLKTFKSLKkTVLHTLLkAISS 1 1 1
Peptide K1D/K3D/K7D /K10D/K14D/K22D
kWkSFLkTFkSLKkTVLHTLLkAISS 1 1 1
Peptide K22D
KWKSFLKTFKSLKKTVLHTLLkAISS 1 1 1
Peptide K3D/K7D /K10D/K14D/K22D
KWkSFLkTFkSLKkTVLHTLLkAISS 1 1 1
Peptide K7D
KWKSFLkTFKSLKKTVLHTLLKAISS 1 1 1
Peptide K7D /K10D/K14D/K22D
KWKSFLkTFkSLKkTVLHTLLkAISS 1 1 1
Peptide K7D /K14D
KWKSFLkTFKSLKkTVLHTLLKAISS 1 1 1
Peptide K7D /K14D/K22D
KWKSFLkTFKSLKkTVLHTLLKAISS 1 1 1
Peptide L12D
KWKSFLKTFKSlKKTVLHTLLKAISS 1 1 1
Peptide L12D/L20D
KWKSFLKTFKSlKKTVLHTlLKAISS 1 1 1
Peptide L20D
KWKSFLKTFKSLKKTVLHTlLKAISS 1 1 1
Peptide L6D
KWKSFlKTFKSLKKTVLHTLLKAISS 1 1 1
Peptide L6D/L12D
KWKSFlKTFKSlKKTVLHTLLKAISS 1 1 1
Peptide L6D/L12D/L17D/L20D
KWKSFlKTFKSlKKTVlHTlLKAISS 1 1 1
Peptide L6D/L12D/L17D/L20D/L21D
KWKSFlKTFKSlKKTVlHTllKAISS 1 1 1
Peptide L6D/L12D/L20D
KWKSFlKTFKSlKKTVLHTlLKAISS 1 1 1
Peptide P
KWKSFLKTFKSLKKTVLHTLLKAISS 1 1 1
Peptide-1
IELLQARGGC-Pem 2 2 1
Peptide-2
IELLQARGGC-Pem-GGRRRRRRRR 2 2 1
Peptide-20
CSSRTMHHC 7 7 1
Peptide-3
RRRRRRRRGGC-Pem 2 2 1
Peptide-327
EFLDCFQKF 6 6 1
Peptide10 Gonearrestide
NDADKDEMQSVYRGKANDDNSRGSKTNHRF 5 5 1
Peptide13 Gonearrestide
WCYKLPDRVSIKEKGRCN 5 5 1
Peptide4 Gonearrestide
ADAPGNYPLDARGKSYYC 5 5 1
Peptide6 Gonearrestide
KLSAIISKIRDE 5 5 1
Pexiganan
GIGKFLKKAKKFGKAFVKILKK 3 3 1
Pexiganan MSI-78
GIGKFLKKAKKFGKAFVKILKK 2 2 1
Phakellistatin 18
PIPYPIF 2 2 1
Phylloseptin
GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS 1 1 1
Phylloseptin-L1
LLGMIPLAISAISALSKL 1 1 1
Phylloseptin-PBa1
FLSLIPHIASGIASLVKNF 5 5 1
Phylloseptin-PBa2
FLSLLPHIASGIASLVSKF 2 2 1
Phylloseptin-PBa3
FLSLIPHIVSGVAALANHL 4 3 1
Phylloseptin-PHa
FLSLIPAAISAVSALANHF 1 1 1
Phylloseptin-PTa
FLSLIPKIAGGIAALAKHL 1 1 1
Picturin 1BN
GIFKDTLKKVVAAVLTTVADNIHPK 3 3 1
Picturin 2BN
GLMDMLKKVGKVALTVAKSALLP 3 3 1
Piscidin 1
FFHHIFRGIVHVGKTIHRLVTG 1 1 1
Piscidin 1, Moronecidin
FFHHIFRGIVHVGKTIHRLVTG 8 4 1
Piscidin 3
FIHHIFRGIVHAGRSIGRFLTG 8 4 1
Plantaricin A
KSSAYSLQMGATAIKQVKKLFKKWGW 1 1 1
Ple
GWGSFFKKAAHVGKHVGKAALTHYL 4 4 1
Ple-a
GWGSFFKKAAHVGKHVGKAALTHYL 6 6 1
PMAP-NC
RIIDRLWLVRRPQKPKFVLVWVL 2 2 1
PNC-28
ETFSDLWKLL 1 1 1
Poca A
GLPCAESCVFIPCTITAILGCSCRDRVCYD 1 1 1
Poca B
GIPCAESCVFIPCVTAILGCSCKDVCYN 1 1 1
Polybia-MP1
IDWKKLLDAAKQIL 1 1 1
Polybia-MPI
IDWKKLLDAAKQIL 1 1 1
Ponericin-W1 (11-25) [P4K; S5K; G8K; K13L; Q15K], At3
KLLKKVVKLFKKLLK 2 2 1
Ponericin-W1 (11-25) [P4K; S5K; G8K; Q15K], At2
KLLKKVVKLFKKKKK 2 2 1
Ponericin-W1 (11-25), At1
KLLPSVVGLFKKKKQ 2 2 1
Prepromelittin-related peptide
AIGSILGALAKGLPTLISWIKNR 1 1 1
Protegrin 1
RGGRLCYCRRRFCVCVGR 2 2 1
Protonectin
ILGTILGLLKGL 2 2 1
Protonectin-F
IFGTILGFLKGL 2 2 1
PS14
PTECQVGTTCKVES 2 1 2
PS9
PSRKVMLWS 2 1 2
PST13-RK
KKKFPWWWPFKKK 2 2 1
Psychrophilin D (1)
lw 1 1 1
Psyle A
GIACGESCVFLGCFIPGCSCKSKVCYFN 1 1 1
Psyle C
KLCGETCFKFKCYTPGCSCSYPFCK 1 1 1
Psyle E
GVIPCGESCVFIPCISSVLGCSCKNKVCYRD 1 1 1
PTP-7a
FLGALFHALSKLL 1 1 1
PTP-7b
FLGALFKALSHLL 1 1 1
PTP-7S
EENFLGALFKALSKLL 2 2 1
PTP1
LLAGLAANFLPTIICKISYKC 5 4 1
PTP2
FAGLAANFLPTIICKISYKC 5 4 1
PTP4
FLKLLKKLAAKFLPTIICKISYKC 5 5 1
PTP5
FLKLLKKLAAKLF 5 5 1
PTP6
FLKLLKKLAAKLF 5 5 1
PTP7
FLGALFKALSKLL 5 5 1
PTP8
FLKLLAGLLKNFA 5 5 1
PTPRJ-pep19
CHHNLTHAC 2 1 1
PTPRJ-pep19.0
CHHNLTHAC 1 1 1
PTPRJ-pep19.2
CAHNLTHAC 3 1 1
PTPRJ-pep19.3
CHANLTHAC 3 1 1
PTPRJ-pep19.4
CHHALTHAC 3 1 1
PTPRJ-pep19.5
CHHNATHAC 2 1 1
PTPRJ-pep19.6
CHHNLAHAC 1 1 1
PTPRJ-pep19.7
CHHNLTAAC 2 1 1
Pugnin A
RLMRIFRILKLAR 2 2 1
Pugnin B
RMMRIFWVIKLAR 2 2 1
PuroA-Arg
FPVTWKWWKWWKG 1 1 1
PuroA-Lys
FPVTWRWWRWWRG 1 1 1
PYL-ME
KIAKVALAKLGIGAVLKVLTTGL 7 6 1
Q7
EQQQQQQPQNRRFRE 1 1 1
R-1
RWQWRWQW 2 2 1
R-1-RR
RWQWRWQWRR 2 2 1
R-C16
RGWFRAMRSIARFIARERLREHL 1 1 1
R-DIM-LF11-334-LF11-334
PWRIRIRRRRIRIRWPPWRIRIRR 3 3 1
R-DIM-LF11-337
PFWRRRIRIRRRRIRIRRRWFP 3 2 2
R-DIM-P-LF11
FQWQRNIRKVRPRVKRINRQWQF 3 3 1
R-DIM-P-LF11-215
FWRIRIRRPRRIRIRWF 3 3 1
R-DIM-P-LF11-322
PFWRIRIRRPRRIRIRWFP 7 3 2
R-DIM-P-LF11-334
PWRIRIRRPRRIRIWP 3 3 1
R-Lycosin I derivative 8a
RGWFRAMRSIARFIARERLRGHL 6 6 1
R-Lycosin I derivative 8b
RGWFRAMRSIARFIARERLRGHL 6 6 1
R11-NLS-pep8
RRRRRRRRRRRIKKKRKWEASALVCIRLVTSSKPRTVa 4 4 1
R2PLx-22
GIMDTVKNAAKNLAGQLLDKLK 5 5 1
r8-BadBH3
rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK 12 4 1
r8-BidBH3
rrrrrrrrGEDIIRNIARHLAQVGDSMDR 12 4 1
r8-BidBH3Alt
rrrrrrrrGEDIIRNIARHAAQVGASMDR 12 4 1
RA-3
RWrGGGGGLFDIIKKIAESF 3 3 1
Ranatuerin-2
GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP 4 4 1
Ranatuerin-2Lb
GILSSIKGVAKGVAKNVAAQLLDTLKCKITGC 4 4 1
Ranatuerin-2PLx
GIMDTVKNAAKNLAGQLLDKLKCKITAC 5 5 1
Ranatuerin-2Ya
GLMDTIKGVAKTVAASWLDKLKCKITGC 1 1 1
Raniseptin-3
AWLDKLKSIGKVVGKVAIGVAKNLLNPQ 1 1 1
Raniseptin-6
ALLDKLKSLGKVVGKVALGVVQNYLNPRQ 1 1 1
Rapeseed peptide
NDGNQPL 2 1 2
RB4
MADSERLSAPGCWAACTNFSRTRK 5 5 1
retro
LGGIVSAVKKIVDFLG 9 9 1
RF13
RRGKGGRRVTMSF 1 1 1
RGD-La
RGDLLRHVVKILEKYL 9 9 1
RGD-Las
RGDLLRHVVKILSKYL 9 9 1
RP-7
RPPCVIL 4 4 1
RP7
ATRQPNH 2 2 1
RP7 SCR
RPPLVIC 4 4 1
RP9
RGSALTHLP 2 2 1
RR-1-R
RRWQWRWQWR 2 2 1
RR-1-RR
RRWQWRWQWRR 2 2 1
RT2
NGVQPKYRWWRWWRRWW 4 4 2
RW-AH
WWRRWWRRWRRWWRRWWR 3 2 2
S-24-R2PLx
GIMDTVKNAAKNLAGQLLDKLKCSITAC 5 5 1
S11D/K14D
KWKSFLKTFKsAKkTVLHTALKAISS 4 4 1
S11D/K14D/T15D
KWKSFLKTFKsAKktVLHTALKAISS 4 4 1
Salamandrin - I
FAVWGCADYRGY 2 1 2
Sample Peptide 1 from EP3604345B1
MQIPQAPWPVVWAVLQLGWRKKRTLRKNDRKKR 5 5 1
Sample Peptide 1 from US011339203B2
LTSVVFILICCFHLENIFVLLKKRTLRKNDRKKR 1 1 1
Sample Peptide 2 from EP3604345B1
MQIPQAPWPVVWAVLQLGWRRKKRRQRRR 3 3 1
Sample Peptide 2 from US011339203B2
FIGNLALSDLLAGVAYTANLLLKKRTLRKNDRKKR 5 5 1
Sample Peptide 3 from EP3604345B1
MRIFAVFIFMTYWHLLNAKKRTLRKNDRKKR 5 5 1
Sample Peptide 3 from US011339203B2
WFLREGSMFVALSASVFSLLAIKKRTLRKNDRKKR 1 1 1
Sample Peptide 4 from EP3604345B1
PWWWPPVVVQQQMILLIGAARKKRTLRKNDRKKR 1 1 1
Sample Peptide 4 from US011339203B2
FLLISACWVISLILGGLPIMGWKKRTLRKNDRKKR 1 1 1
Sample Peptide 5 from EP3604345B1
KKRTLRKNDRKKR 1 1 1
Sample Peptide 6 from US011339203B2
VIIVLSVFIACWAPLFILLLLKKRTLRKNDRKKR 1 1 1
Sample Peptide 7 from US011339203B2
LFRAEYFLVLAVLNSGTNPIIKKRTLRKNDRKKR 1 1 1
Sansalvimide A
LXVLF 3 3 1
SB-37 AC
MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG 7 6 1
SB-37 AM
MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG 7 6 1
Sema3A(aa363-377) -nLytic
NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL 4 4 1
Sema3A(aa371-377) -nLytic
GRVPYPRGGLLkLLKklLKKLlKL 4 4 1
Seq ID No. 15 from patent ID US202000079827A1
LKKWWKKVKGLLGGLLGKVTSVIK 3 3 1
Seq ID No. 16 from patent ID US202000079827A1
LKKWWKKVKGLLGGLLGKVKSVIK 3 3 1
Seq ID No. 17 from patent ID US202000079827A1
LKKWWKKVKGLLGGLLGKVKKVIK 3 3 1
Seq ID No. 26 from patent ID US202000079827A1
RRWVRRVRRVWRRVVRVVRRWVRR 2 2 1
Seq ID No. 34 from patent ID US202000079827A1
RRWvRRvRRvWRRvvRvvRRWvRR 2 2 1
Sesquin
KTCENLADTY 1 1 1
SHIVA 10 (1-16)
KTKLFKKFAKKLAKKLKKLAKKL 1 1 1
SHIVA 10 (1-16) Ac
KTKLFKKFAKKLAKKLKKLAKKL 6 5 1
SHIVA 10 AC
FAKKLAKKLKKLAKKLAKLALAL 7 6 1
SHIVA 10 PEPTIDE 71 + KWKL
FAKKLAKKLKKLAKKLAKKWKL 7 6 1
Shiva 10(1-18 AC)
FAKKLAKKLKKLAKKLAK 7 6 1
SHIVA 11[(1-16)ME(2-9]-COOH
FAKKLAKKLKKLAKKLIGAVLKV 7 6 1
SHIVA DERIV P69 + KWKL
FAKKLAKKLKKLAKKLAKKWKL 7 6 1
Shiva-1
MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG 4 4 1
Shiva-11
FAKKLAKKLKKLAKKLAKLALALKALALKAL 7 6 1
Short α-helical peptides
GIIKKIIKKIIKKIIKKI 6 2 1
Si1
(KLAKLAK)2 2 2 1
Si11
KL(Beta-A)KL(Beta-A)K 2 2 1
Si13
KnLAKnLAK 1 1 1
Si14
KnLAKnLAK 2 2 1
Si15
KnLAKnLAK 2 2 1
Si2
KL(Beta-A)KL(Beta-A)K 2 2 1
Si3
KL(Beta-A)KL(Beta-A)AK 1 1 1
Si7
KLAKLAK 1 1 1
Si8
KLAKLAK 2 2 1
SKACP003
FPLPCAYKGTYC 3 3 1
SmacN7-Arg8 fused peptide P4
Ahx-AVPIAQK(KRRRRRRRRRE) 1 1 1
SmacN7-Arg8 fused peptide P5
Ahx-(KAVPIAQKE)RRRRRRRR 1 1 1
SmacN7-Arg8 fused peptide P7
Ahx-(KAVPIAQKE)GG(KRRRRRRRRE) 1 1 1
SMP24
IWSFLIKAATKLLPSLFGGGKKDS 9 7 3
SOR-C13
KEFLHPSKVDLPR 1 1 1
SSTP1
FLPLLISALTSLFPKLGK 2 2 1
ST101
vaeareelerlearlgqargelkkwkmrrnqfwlklqr 6 6 1
Sur-X
YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM 4 4 1
SVS-1
KVKVKVKVpPTKVKVKVK 4 4 1
SVS-2
KVKVKVKVPPTKVKVKVK 4 4 1
Synthetic peptide
KWKKLLKKPPPLLKKLLKKL 6 3 1
T Peptide
TKPRKTKPRKTKPRKTKPR 3 3 1
t-DPH1
GLWSKIKNVAAAAGKAALGAL 4 4 1
t-DPH1-5K
GLWKKIKNVAKAAGKAALGAL 4 4 1
t-DPH1-6K
GLWKKIKNVAKAAGKAAKGAL 4 4 1
t-DPH1-6KW
WLWKKIKNVAKAAGKAAKGAL 4 4 1
t-DPH1-K4
GLWKKIKNVAAAAGKAALGAL 4 4 1
T1
KWCFRVCYRGICYRRCR 7 7 1
Tachyplesin
KWCFRVCYRGICYIRRCR 2 2 1
TAK-448
ywNTF(AzGly)R(Me)W 1 1 1
Tat
RKKRRQRRR 1 1 1
Tat (47-57)
YGRKKRRQRRR 3 1 1
TAT-2D5
GRKKRRQRRRPPQGGLTIYFY 1 1 1
TAT-327
RKKRRQRRREFLDCFQKF 5 5 1
Tat-a5
KAQIRAMECNILGRKKRRQRRR 1 1 1
TAT-Ras-GAP317-326
GRKKRRQRRRGGWMWVTNLRTD 4 1 1
TC22
MTVVLLLIVLPLLGGVHSSGIL 2 2 1
Tempoprin-1CEa
FVDLKKIANIINSIF 7 3 2
Temporin A
FLPLIGRVLSGIL 2 2 1
Temporin L
FVQWFSKFLGRIL 1 1 1
Temporin-1CEb
ILPILSLIGGLLGK 1 1 1
Temporin-1Ga
SILPTIVSFLSKVF 1 1 1
Temporin-1Oc
FLPLLASLFSRLF 2 2 1
Temporin-1OLa
FLPFLKSILGKIL 1 1 1
Temporin-CPa
IPPFIKKVLTTVF 1 1 1
Temporin-HLa
FFPLIFGALSSILPKIL 3 3 1
Temporin-La
LLRHVVKILEKYL 9 9 1
Temporin-Las
LLRHVVKILSKYL 9 9 1
Temporin-PE
FLPIVAKLLSGLL 4 4 1
temporin-PEa
FLYIVAKLLSGLL 4 4 1
temporin-PEb
FLPIVAKLLSGLLGRKKRRQRRR 4 4 1
Temporin-PKE
FLPLIIGALSSLLPKIF 5 5 1
Temporin-PKE-2K
FLPLIIGKLSSLLPKIF 5 5 1
Temporin-PKE-3i
FLPLiiGALSSLLPKiF 5 5 1
Temporin-PKE-3K
FLPKIIGKLSSLLPKIF 5 5 1
Temporin-PKE-4K
FLPKIIGKLSSKLPKIF 5 5 1
Temporin-PKE-i
FLPLIIGALSSLLPKiF 5 5 1
Temporin-PKE-K12
FLPLIIGALSSKLPKIF 5 5 1
Temporin-SHf
FFFLSRIF 4 4 1
Test peptide
YSFGL 2 2 1
Tetramer of peptide-paclitaxel conjugate
(K-Aib-C(CH2CO-2'-Pac))4 3 3 1
TG20
NHFTLKCPKTALTEPPTLAY 36 6 1
TG23
TAGIKLTVPIEKFPVTTQTFWG 36 6 1
tMP-C
RKKRRQRRRLNLKALLAVAKKIL 5 5 1
TP
ASVVNKLTGGVAGLLK 2 2 1
TP4
FIHHIIGGLFSAGKAIHRLIRRRRR 8 7 3
trans-Phakellistatin 18
trans(P)PIPYPIF 1 1 1
Transferrin receptor (TfR)-lytic hybrid peptide
THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK 12 12 1
trichoderin A
MDA-P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 12
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 13
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 14
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 15
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 16
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 17
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 18
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 19
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
trichoderin A analogue 4
P-Cha-Aib-Aib-IV-Aib-Aib-AMAE 2 2 2
Trichogin GA
UGLUGGLUGI 2 2 1
Trimer of peptide-paclitaxel conjugate
(K-Aib-C(CH2CO-2'-Pac))3 3 3 1
Tritrp DiSu
CVRRFPWWYPFLRRC 1 1 1
Tritrp-Agb
V(Agb)(Agb)FPWWWPFL(Agb)(Agb) 1 1 1
Tritrp-Arg
VRRFPWWWPFLRR 1 1 1
Tritrp-Dab
V(Dab)(Dab)FPWWWPFL(Dab)(Dab) 1 1 1
Tritrp-Dap
V(Dap)(Dap)FPWWWPFL(Dap)(Dap) 1 1 1
Tritrp-hArg
V(hArg)(hArg)FPWWWPFL(hArg)(hArg) 1 1 1
Tritrp-Lys
VKKFPWWWPFLKK 1 1 1
Tritrp-Orn
V(Orn)(Orn)FPWWWPFL(Orn)(Orn) 1 1 1
Tritrp-P59A
VRRFAWWWAFLRR 1 1 1
Tritrp-P59A-Lys
VKKFAWWWAFLKK 1 1 1
Tritrp-P5A
VRRFAWWWPFLRR 1 1 1
Tritrp-P5A-Lys
VKKFAWWWPFLKK 1 1 1
Tritrp-P9A
VRRFPWWWAFLRR 1 1 1
Tritrp-P9A-Lys
VKKFPWWWAFLKK 1 1 1
Tritrp-W678A
VRRFPAAAPFLRR 1 1 1
Tritrp-W678bTA
VRRFP(bTA)(bTA)(bTA)PFLRR 1 1 1
Tritrp-W678F
VRRFPFFFPFLRR 1 1 1
Tritrp-W678Y
VRRFPYYYPFLRR 1 1 1
Tritrp-W67A
VRRFPAAWPFLRR 1 1 1
Tritrp-W67Y
VRRFPYYWPFLRR 1 1 1
Tritrp-W68A
VRRFPAWAPFLRR 1 1 1
Tritrp-W68Y
VRRFPYWYPFLRR 1 1 1
Tritrp-W6A
VRRFPAWWPFLRR 1 1 1
Tritrp-W6hW
VRRFP(hW)WWPFLRR 1 1 1
Tritrp-W6Y
VRRFPYWWPFLRR 1 1 1
Tritrp-W789hW
VRRFP(hW)(hW)(hW)PFLRR 1 1 1
Tritrp-W78A
VRRFPWAAPFLRR 1 1 1
Tritrp-W78Y
VRRFPWYYPFLRR 1 1 1
Tritrp-W7A
VRRFPWAWPFLRR 1 1 1
Tritrp-W7hW
VRRFPW(hW)WPFLRR 1 1 1
Tritrp-W7Y
VRRFPWYWPFLRR 1 1 1
Tritrp-W8A
VRRFPWWAPFLRR 1 1 1
Tritrp-W8hW
VRRFPWW(hW)PFLRR 1 1 1
Tritrp-W8Y
VRRFPWWYPFLRR 1 1 1
Tritrpticin
VRRFPWWWPFLRR 3 3 2
TsAP-1
FLSLIPSLVGGSISAFK 2 2 1
TsAP-2
FLGMIPGLIGGLISAFK 5 5 1
TsAP-S1
FLSLIPKLVKKIIKAFK 5 5 1
TsAP-S2
FLGMIPKLIKKLIKAFK 5 5 1
Turgencin A
GPKTKAACKMACKLATCGKKPGGWKCKLCELGCDAV 1 1 1
Turgencin B
GIKEMLCNMACAQTVCKKSGGPLCDTCQAACKALG 1 1 1
Tyroserleutide
YSL 8 2 1
U3
NGSIPATWASL 3 3 1
U7
NCSIHGDIPAY 3 3 1
V13K
KWKSFLKTFKSAKKTVLHTALKAISS 4 4 1
Vaby A
GLPVCGETCAGGTCNTPGCSCSWPICTRN 1 1 1
Vaby D
GLPVCGETCFGGTCNTPGCTCDPWPVCTRN 1 1 1
Varv peptide A
GLPVCGETCVGGTCNTPGCSCSWPVCTRN 1 1 1
Varv peptide F
GVPICGETCTLGTCYTAGCSCSWPVCTRN 1 1 1
vCPP0275
KKRYKKKYKAYKPYKKKKKF 2 2 1
vCPP0667
RPRRRATTRRRITTGTRRRR 3 3 1
vCPP0769
RRLTLRQLLGLGSRRRRRSR 4 4 1
vCPP2319
WRRRYRRWRRRRRWRRRPRR 4 4 1
Viba 15
GLPVCGETCVGGTCNTPGCACSWPVCTRN 1 1 1
Viba17
GLPVCGETCVGGTCNTPGCGCSWPVCTRN 1 1 1
Vibi E
GIPCAESCVWIPCTVTALIGCGCSNKVCYN 1 1 1
Vibi G
GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN 1 1 1
Vibi H
GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN 1 1 1
Vigno 5
GLPLCGETCVGGTCNTPGCSCGWPVCVRN 1 1 1
Viphi E
GSIPCGESCVFIPCISAVIGCSCSNKVCYKN 1 1 1
Viphi F
GSIPCGESCVFIPCISAIIGCSCSSKVCYKN 2 1 1
Viphi G
GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN 1 1 1
VISHNU3
MPKEKVFLKIEKMGRNIRN 7 6 1
VLL-28
VLLVTLTRLHQRGVIYEKWRHFSGRKYR 1 1 1
VmCT1
FLGALWNVAKSVF 1 1 1
VS-9
VKLRSLLCS 2 2 1
WP1
RLLRLMRLRMLLRM 4 4 2
WP2
RLLRLLRLRRLLRL 4 4 2
XLAsp-P1
DEDDD 1 1 1
YT12
YFYPKDFTPGCT 1 1 1
Z-1
L(N-Me-L)LPL 5 5 1
Z-2
LPLPL 6 5 1
Z-3
lPLPL 5 5 1
Z-4
LPlPL 5 5 1
Z-5
LPLPl 4 4 1
Z-6
lPLPl 5 5 1
Z-7
LPlPl 5 5 1
Z-8
lPlPl 5 5 1
Z1
KAAKKWAKAAKKWAKAWKKAA 3 3 1
Z10
AAKKWAKAKWAKAKKWAKAA 3 3 1
Z2
KAAKKWAKAWKKAAKAWKKAA 3 3 1
Z24
ALSKALSKALSKALSKALSKALSK 10 10 1
Z3
KAAKKAWKAWKKAAKAAWKKAA 3 3 1
Z4
KAAKKAWKAAKKAAKWWKKAA 3 3 1
Z44
ALSKALSKALSKALSKALSKALSK 10 10 1
Z5
KAAKKAWKWAKKAAKWAKKAA 3 3 1
Z6
KWWKKAAKAAKKAAKAAKKWA 3 3 1
Z7
KAAKKAWKAAKKAWKAAKKAA 3 3 1
Z8
AWKKWAKAWKWAKAKWWAKAA 3 3 1
Z9
AAWKWAWAKKWAKAKKWAKAA 3 3 1
ZXR-1
FKIGGFIKKLWRSKLA 6 6 1
ZXR-2
FKIGGFIKKLWRSLLA 7 6 2
[A18K]OCN-3N
GIFDVLKNLAKGVITSLKS 3 3 1
[Arg2] TG
URLUGGLUGI 2 2 1
[Arg]11-VmCT1
FLGALWNVAKRVF 1 1 1
[Arg]3-VmCT1
FLRALWNVAKSVF 1 1 1
[Arg]7-VmCT1
FLGALWRVAKSVF 1 1 1
[C/U, G1K, L5Y, K8R]cGm
KURRYUYRQRUVTYURGR 6 6 1
[C/U]cGm
GURRLUYKQRUVTYURGR 6 6 1
[D-P L-P]cGm
GCRRLCYKQRCVTYCRGpPR 4 4 1
[D4K,A18K]OCN-3N
GIFKVLKNLAKGVITSLKS 3 3 1
[D4K]OCN-3N
GIFKVLKNLAKGVITSLKS 3 3 1
[D9K]Hymenochirin-1B
IKLSPETKKNLKKVLKGAIKGAIAVAKMV 3 3 1
[G10a]-SHa
FLSGIVGMLaKLF 7 7 1
[G10a]2-SHa
FLSGIVGMLaKLFKFLKaLMFLSGIVG 7 7 1
[G10a]SHa
FLSGIVGMLaKLF 3 3 1
[G10a]SHa-BCTP
FLSGIVGMLaKLFLFKQYAELW 3 3 1
[G18K]cT1
KWCFRVCYRGICYRRCRK 5 5 1
[G1K, K8R]cGm
KCRRLCYRQRCVTYCRGR 6 6 1
[G1K, L5Y, K8R]cGm
KCRRYCYRQRCVTYCRGR 6 6 1
[G4,7,10a]SHa
FLSaIVaMLaKLF 3 3 1
[G4,7a]SHa
FLSaIVaMLGKLF 3 3 1
[G4a]SHa
FLSaIVGMLGKLF 3 3 1
[G7,10a]SHa
FLSGIVaMLaKLF 3 3 1
[G7a]SHa
FLSGIVaMLGKLF 3 3 1
[I11F-G18K]cT1
KWCFRVCYRGFCYRRCRK 5 5 1
[K8R]cGm
GCRRLCYRQRCVTYCRGR 4 4 1
[L5W]cGm
GCRRWCYKQRCVTYCRGR 4 4 1
[L9]-P18
KWKLFKKILKFLHLAKKF 3 3 1
[Lys5,6] TG
UGLUKKLUGI 2 2 1
[Lys6] TG
UGLUGKLUGI 2 2 1
[P5K,D9K]Hymenochirin-1B
IKLSKETKKNLKKVLKGAIKGAIAVAKMV 3 3 1
[P5K]Hymenochirin-1B
IKLSKETKDNLKKVLKGAIKGAIAVAKMV 3 3 1
[R/K]cT1
KWCFKVCYKGICYKKCKG 4 4 1
[R14S]cT1
KWCFRVCYRGICYSRCRG 5 5 1
[R17S]cT1
KWCFRVCYRGICYRRCSG 5 5 1
[R4A, R18A]cGm
GCRALCYKQRCVTYCRGA 6 6 1
[R9S-R14S-R17S]cT1
KWCFRVCYSGICYSRCSG 3 3 1
[R9S]cT1
KWCFRVCYSGICYRRCRG 1 1 1
[S9]-P18
KWKLFKKISKFLHLAKKF 3 3 1
[TOAC1, Api4] TG
XGLZGGLUGI 1 1 1
[TOAC1, Arg2] TG
XRLUGGLUGI 2 2 1
[TOAC1, Arg9] TG
XGLUGGLURI 2 2 1
[TOAC1, Lys5,6] TG
XGLUKKLUGI 2 2 1
[TOAC1, Lys6] TG
XGLUGKLUGI 2 2 1
[TOAC1] TG
XGLUGGLUGI 2 2 1
[W2S]cT1
KSCFRVCYRGICYRRCRG 6 6 1
[Y14W]cGm
GCRRLCYKQRCVTWCRGR 4 4 1
[Y7W, K8R, Y14W]cGm
GCRRLCWRQRCVTWCRGR 5 5 1
[Y7W]cGm
GCRRLCWKQRCVTYCRGR 4 4 1
[Y8S-I11S]cT1
KWCFRVCSRGSCYRRCRG 4 4 1
αs1-casein f(90_95)
RYLGYL 1 1 1
β-Casomorphins 5 f(60_64)
YPFPG 1 1 1
ΔM4
NFFKRIRRAWKRIWKWIYSA 1 1 1